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Background: Previous clinical research of football players participating in 
international tournaments has mainly focussed on documentation of injuries and risk 
factors for injury.  However, despite anecdotal evidence that medical 
symptomatology, illness and medical complaints are common during travel to 
international competitions, the epidemiology of medical conditions before, during or 
after elite level football tournaments, has not been well documented. 
Objective: The aims of the research presented in this dissertation were: 1) to 
determine the prevalence of medical conditions in elite football players 2) to 
determine the incidence and nature of medical conditions and illness in the elite 
football players participating in an international tournament (2009 FIFA 
Confederations Cup tournament) and 3) to provide data for the medical planning 
and management of elite football players during future events. 
Methods: The first component of this dissertation consisted of a comprehensive 
review of the current literature describing the prevalence and incidence of medical 
conditions and illness in athletes.  The original research component of this 
dissertation consisted of two parts, and both studies were conducted during the 
FIFA Confederations Cup tournament, which was held in South Africa in June 2009. 
All the players in the 8 participating teams (23 players per team – a total of 184 
players) were approached by the FIFA Medical Assessment and Research Centre 
(F-MARC) through their team physicians and invited to participate as research 
subjects in the studies.  Part 1 (descriptive cross-sectional study):  Prior to the 
tournament, all the players completed a previously validated medical history and 
illness questionnaire.  Furthermore, the questionnaire contained sections on player 
demographics, training history, medication and supplement use, life-style history, 




sections pertaining to upper respiratory tract infections (URTI), allergies, asthma, 
exercise associated muscle cramping (EAMC) and history of previous surgery.  Part 
2 (prospective cohort study):  During the 15 days of the tournament each team 
physician was requested to complete a daily injury, medical illness and treatment log 
for each player.  Finally, data on the environmental conditions at each venue were 
collected, as recorded by the South African Weather Service. 
Results: The main findings in part 1 of this study were: 1) exercise associated 
muscle cramping (EAMC) was the most prevalent medical condition reported, with 
64 (46%) of the players reporting a history of EAMC, 2) the prevalence of allergy 
was 27 (20%) and asthma 6 (4%), 3) the prevalence of dermatological conditions 
was 16 (12%), 4) the prevalence of gastro-intestinal conditions was 10 (7%) and 
central nervous system conditions was 6 (4%), 5) URTI one week before the 
tournament was reported by 7 (5%) of the players, 6) 68 (49%) of the players 
reported a history of previous surgery and 7) 72 (52%) of the players reported the 
use of supplements or vitamins and 11 (8%) the use of medication.  Knee surgery 
was the most common anatomical area operated with 33 (24%) of the players 
reporting previous knee surgery.  This was followed by a much lower prevalence of 
ankle surgery, 8 (6%). 
In part 2 of the study, a total of 56 injuries and 35 illnesses were recorded during the 
tournament.  The main findings in this study were: 1) an overall injury rate of 64.4 
injuries per 1000 match hours or 2.1 injuries per match, 2) an overall rate of 2.7 
injuries and 1.7 illnesses per 100 player days, 3) that 0.88 days were lost per injury 
and 0.46 days were lost per illness, 4) the lower limb was the most commonly 
injured body part, 5) 11 (20%) of the injuries reported were to the thigh, 6) 15 (44%) 
of the injuries reported were due to a contusion, 6) 13 (37%) of the illnesses 





Summary and conclusion: Illness and injury are common during an international 
football tournament.  The pattern of injury was similar to that previously reported.  
However, the novel finding of this dissertation was that illness is a significant 
component to the medical care to a travelling team and needs to be considered by 
team physicians managing the medical needs of elite football teams. 





Introduction and scope of the dissertation 
The 8th FIFA Confederations Cup football tournament, in which 8 international 
football teams competed, was held from the 14th to the 28th of June 2009 in South 
Africa.  This tournament is played every 4 years, 1 year before the FIFA World Cup 
football tournament.  The tournament, also known as the “festival of champions”, is 
considered a prestigious warm-up tournament for the next FIFA World Cup.  
Furthermore, this tournament was also used to evaluate the medical facilities and 
environmental conditions in South Africa, the host country for the 2010 FIFA World 
Cup tournament. 
The 2009 FIFA Confederations Cup football tournament was played between the 
winners of each of the FIFA confederations regional tournaments, the previous FIFA 
World Cup winners (Italy) and the next FIFA World Cup tournament host countries 
national team (South Africa).  This tournament was comprised of 8 international 
teams each consisting of 23 players, a total of 184 players, and included the teams 
from Brazil, Egypt, Iraq, Italy, New Zealand, South Africa, Spain and the United 
States of America.  These teams and their regional representations are listed in 
Appendix 1.  The 4 host city venues for the tournament in South Africa were 




This was the first time that this tournament was held in Africa and meant that 
participating players from all over the world had to travel to South Africa. The 
tournament also took place in the winter season, a novelty for a FIFA 
Confederations Cup or World Cup tournament.  The participating players were thus 
potentially exposed to the specific environmental conditions and possibly new 
infective agents in South Africa at the time of the tournament.  During the 
tournament itself, the players were also exposed to demanding physical challenges 
(for example; climatic extremes, pollution in large cities and alteration to sleep 
cycles) that may have negatively affected their general health. 
 
It is well recognised that team physicians attending to athletes medical needs will 
encounter non-trauma related medical problems. Such medical conditions and 
illnesses associated with exercise in elite professional footballers participating in a 
tournament can affect many of the body organ systems including; the respiratory, 
gastrointestinal, dermatological, cardiovascular, musculoskeletal, neurological, 
metabolic, endocrine or urogenital systems.  It is not currently known what patterns 
of medical complaints occur during large international football tournaments or how 
many of these complaints are due to pre-existing medical conditions.  The 
prevalence of medical complaints in the participants prior to a tournament and the 
incidence of medical conditions and illness during elite athletic tournaments have 
not been well studied.  In this dissertation, the focus will be on the prevalence and 
incidence of medical conditions and illness experienced before and during an 






To date, the majority of research studies that have examined medical conditions 
during competitive football and other sporting events have focussed on the 
incidence and nature of injuries only.  Injury surveillance systems for football and 
multi-sports tournaments such as the Olympic Games have been well described and 
the standardization of injury definitions and surveillance methodology has been 
accepted by experienced team physicians1,2.  Yet, illness surveillance has not been 
well researched and thus an approach to standardize methodologies of illness 
surveillance does not currently exist.  However, the injury surveillance system in the 
future Olympic Games will include disease conditions as well as injury data3.  A 
number of studies have reported medical complaints in specific systems and the 
main focus of these studies has been on respiratory tract symptoms after 
competitions4,5.  The outbreak of infective medical conditions during sports 
participation has also received some attention and a review of such outbreaks has 
been published6.  A limited number of studies have documented medical conditions 
and illness in athletes and the results of these studies suggest that the incidence 
and nature of medical conditions experienced by elite athletes while participating in 
large sporting events is similar across various sporting codes and events.  However, 
further research is needed to accurately document the patterns and significance of 
disease in the various sporting codes and in particular in football.  In football players, 
the incidence and prevalence of medical conditions and illness, including respiratory 
tract symptoms in relation to training, competition and travel to international 







In chapter 2 of this dissertation the current literature pertaining to the occurrence of 
medical conditions and illness in athletes and the reporting thereof before, during 
and after elite international sporting events will be reviewed.  In particular the 
following will be discussed:  1) medical conditions and symptomatology reported by 
athletes prior to events, 2) medical conditions recorded during sports participation 
and 3) medical conditions related to travelling to and participation in elite 
international sporting events. 
 
Chapters 3 and 4 focus on, the original research component of this dissertation and 
on the following 2 studies: 1) the prevalence of pre-competition medical conditions in 
elite football players and 2) the incidence of medical complaints and illness during 
an elite international football event.  Furthermore, the effects of pre-tournament 
medical complaints, medical history, environmental conditions and training load on 
the incidence of medical conditions and illness experienced during competition will 
be explored.  As this was the first study of this nature, the present study served as a 
reference for research that was conducted during the subsequent 2010 FIFA World 
Cup tournament.  Therefore, this study also served as an initiative to further develop 
and standardize the research methodology that can be used during subsequent elite 
sporting events for the collection of illness data.  Finally, the results of this research 
provide practical guidelines for those tasked with the medical care of athletes.    
 
In chapter 5 of this dissertation, the main findings will be summarized and clinical 
guidelines for sports physicians and event organisers regarding the prevention and 
management of medical conditions and illness during elite international sporting 





Medical conditions and illness in elite athletes:  A review of 
the reported prevalence and incidence of medical conditions 





Sport, whether practiced for recreational or health purposes or as a profession is 
practiced by millions of individuals all over the world.  It is well established that 
regular physical exercise is beneficial in the primary and secondary prevention of 
chronic diseases of lifestyle, including coronary heart disease, hypertension, cancer, 
obesity and diabetes mellitus.  The health benefits of regular physical activity were 
emphasized in a recent publication naming physical inactivity as arguably the most 
important public health threat of the 21st centruy7.  There is thus a perception that 
athletes, due to their participation in regular exercise and subsequent physical 
fitness, are generally healthy and that their participation in exercise training protects 
them against the risk of acquiring medical conditions and illnesses.  The reporting of 
medical problems encountered by athletes has traditionally focussed on injuries, yet 
the medical conditions including systemic conditions such as respiratory tract 
complaints, central nervous system conditions, exercise associated muscle 
cramping and infections, have largely been neglected.  Indeed, when infection is 
considered, epidemiological evidence suggests that increased exercise training load 




increased risk of developing illnesses or infections8,9.  A popular working theory 
regarding exercise and infection is the J-curve proposed by Nieman10.  According to 
this theory, regular moderate exercise decreases the risk of infection to below that of 
sedentary individuals, whereas strenuous, intense exercise increases risk of 
infection above that of sedentary individuals.  The J-curve theory is supported by a 
recent study which confirmed an association between the volume and intensity of 
exercise and the incidence of upper respiratory illness (URI)11.  However, more 
evidence is needed before the J-curve can be accepted as subject numbers in the 
existing studies are small and rely on patient recall or self reporting of the diagnosis 
of illness.  The exact frequency, duration, type and intensity of exercise required to 
optimally lower ones risk of infection or to adversely increase the risk of infection 
remains to be determined.  Also, pathogen exposure, stress, sleep, nutrition and the 
environment affect the immune system and play a confounding role in the 
occurrence of illness in athletes.  These factors have also not been investigated 
fully12-14.  Furthermore, elite athletes participating at higher than recreational levels 
of sporting performance will compete at a high intensity and spend many hours 
daily, training for their events.  This physical stress is often compounded by the 
psychological demands of international sport as well as the travel related stress of 
getting to and being in the environment of the event destination.  These additional 
factors may further predispose elite athletes to a higher risk of medical conditions 
and illness12.  Therefore, international sporting tournaments require significant 
preparation by the host countries medical team and physical and emotional 







The environment in which athletes compete, train and reside, both domestically and 
internationally provide varied opportunities for the transmission of infectious 
organisms via airborne, person to person or common-source exposures6.  
Furthermore, 59 infectious disease outbreaks reported in competitive sports from 
1922 till 2005 were identified and reviewed recently6.  Another review of infections in 
athletes suggested that athletes do indeed have an increased risk of developing 
illnesses but concluded that more research was needed to determine the 
mechanism of transmission15.  The precise aetiology and pathogenesis of illness, in 
particular respiratory tract symptoms in athletes during training and competition, is 
not clear.  However, a popular hypothesis is that alterations in the immune system 
allow post-exercise infections to develop9,16-20.  This hypothesis has however 
recently been challenged due to the findings that evidence of actual infection has 
not been consistently documented either clinically, serologically or through the 
culture of organisms21,22.  In a study investigating the association of exercise and 
URI, pathogens were identified in less than 30% of the affected athletes11.  Further 
investigations are needed to determine the cause of illness in the symptomatic URI 
athletes where a causative agent could not be identified.  Furthermore, despite 
numerous attempts to describe an association between post-exercise immunity and 
upper respiratory tract infections, no clear relationship between altered immune 
parameters and upper respiratory tract symptoms has been documented21-23.  
Therefore, the hypothesis that infection is responsible for respiratory tract symptoms 
in athletes, particularly after endurance events requires further study, or alternative 
hypotheses need to be considered.  There is a growing interest in the prevalence 




The majority of the previous studies investigating elite sporting tournaments have 
focused on injury reporting and only limited studies have reported on the incidence 
of illness. In football, injury research methodology has been well described by an 
injury consensus group established under the auspices of F-MARC, who defined 
topics such as the definition of injury, recurrent injuries, injury severity, training and 
match exposure, as well as criteria for classifying injuries according to location, type, 
diagnosis and cause24.  However, no such research methodology has been 
described for medical conditions and illness reporting.  The focus of this review is on 
illness, where applicable references and comparisons of injury data and illness data 
will be discussed.  Football injuries will not be reviewed in this chapter as they have 
been well reported and reviewed elsewhere25,26.   
This review will therefore focus on the epidemiology (prevalence and incidence) of 
medical conditions and illness experienced by elite international athletes and the 
following definitions of the terminology used throughout this thesis are therefore of 
importance27: 
The point or current prevalence of a condition is defined as the relative 
frequency (number of cases) of the condition present in a cohort population 
at a particular moment in time. 
The life-time prevalence of a condition is defined as the relative frequency 
(number of cases) of the condition having previously been present in a 
cohort population at any stage in their life-time (over a period of time). 
The incidence of a condition is defined as the relative frequency (number of 




The relationship between pre-existing medical conditions reported by athletes before 
a competition (prevalence) and the medical conditions recorded during a completion 
(incidence) has not been examined.  Of particular interest in this review are the 
medical conditions experienced by elite football players prior to, during and after 
international tournaments.   
 
The review is divided into the following sections.  In section 2.2., the prevalence of 
medical conditions and illnesses in athletes will be reviewed and in section 2.3., the 
incidence of medical conditions and illness during sporting participation will be 
reviewed.  Finally in section 2.4., general medical conditions and travel related 
medical problems in elite athletes participating in international events will be 
reviewed. 
 
2.2. The prevalence of medical conditions and illnesses in elite athletes 




The prevalence of medical conditions affecting athletes prior to participation in elite 
international sporting events have been reported previously, but have not been well 
studied.  Indeed, only limited data exist in few selected sports.  These include a 
review of common illnesses and injuries limiting competitive swimming28, a 
descriptive review of infectious diseases in rugby players29, a 12 year profile of the 




medical conditions in participants, prior to and during the 1980 Melbourne 
marathon31.  Medical conditions were reported in 33% of the 459 participants prior to 
the 1980 Melbourne Marathon.  In these athletes, 51% reported unspecified 
musculo-skeletal conditions and 23% respiratory tract illness (RTI) or viral infections 
and 10% reported gastrointestinal conditions31.  A review of the current literature 
failed to identify studies outlining the prevalence of pre-competition general medical 
conditions in elite football players.  The findings of a pre-participation physical 
examination focussing on unknown or undiagnosed heart conditions including 
congenital cardiomyopathy in the participants of the final rounds of the 2006 FIFA 
World Cup have been published25.  However, to date, the general medical history 
and examination data of the other body systems collected in these footballers has 
not been published. 
 
In elite football players, the overall prevalence of medical conditions and illness, 
including upper respiratory tract symptoms (URTS) in relation to training and 
competition has not been documented.  This review will focus on all medical 
conditions and illnesses as reported during elite sporting events.  The review will 
emphasise URTS as this is one of the most commonly reported medical problems in 
athletes.  The studies that have reported the prevalence of specific medical 









2.2.2. Cardiovascular system 
 
The true prevalence of heart disease in athletes is difficult to determine as the 
majority of athletes with underlying heart disease or those who suffer a sudden 
cardiac death do not experience any warning symptoms32.  However, a periodic 
health examination (PHE) has been suggested as a means to detect underlying 
cardiac disease in athletes3.  Exercise or sports-related sudden cardiac death is a 
rare event.  However, when it does occur, the most common causes in athletes 
have been reported as hypertrophic cardiomyopathy (24-36%), coronary artery 
abnormalities (18-24%), Marfan syndrome (4%) and mitral valve prolapsed (4%)32-36.  
The prevalence of hypertrophic cardiomyopathy in young Italian footballers is lower 
than other population groups (2%) and arrythmogenic right ventricular dysplasia / 
cardiomyopathy was reported to account for the most (22%) sudden cardiac deaths 
in young Italian athletes37,38.    Periodic health examinations with specific emphasis 
on electrocardiogram (ECG) and cardiac echocardiogram (ECHO) are currently not 
routinely conducted.  In the majority of sporting codes these examinations have only 
recently been included as part of the PHE as a result of the consensus statement of 
the IOC3.  However, a pre-participation medical examination focussing on unknown 
cardiac disease and the prevention of sudden cardiac death was required for all the 
players participating in the FIFA 2006 World Cup in Germany.  This information was 
collected by F-MARC prior to the tournament25.  This study found that about 1% of 
the players required further cardiac assessment from the information gathered 






2.2.3. Respiratory system 
 
2.2.3.1. Terminology and definitions 
 
Athletes can present with respiratory tract symptoms ranging from a blocked or 
“runny” nose to coughing and chest pain.  These symptoms may be accompanied 
by additional systemic symptoms such as fever, headache, muscle pain and general 
fatigue.  It has been suggested that if an athlete has a common cold (“runny” nose 
and sore throat without a fever or general body pain) then exercise training may be 
resumed a few days after the resolution of the symptoms.  However, if the athlete 
complains of fever, fatigue, muscle aches and lymph gland swelling, 2 to 4 weeks 
should be allowed before intensive training can be resumed13.  To describe these 
clinical presentations more accurately it has been proposed that the terms Upper 
Respiratory Tract Symptoms (URTS) (blocked or “stuffy” nose, “runny” nose, sore 
throat), Lower Respiratory Tract Symptoms (LRTS) (cough, wheeze, chest pain) and 
systemic symptoms (fever, muscle aches, joint pain, general fatigue) be used40. 
      
2.2.3.2. Respiratory system 
 
Respiratory symptoms suggestive of asthma are common in athletes41. The 
prevalence of asthma in athletes appear to be higher than that of the normal 
population and varies from 3-30% in summer sports42 and 12-60% in winter sports43 
depending on the environment in which it is measured, the highest prevalence 




2.2.3.3. Ear, nose and throat and atopic illness    
 
The prevalence of atopic illness in the general population is not known but allergies 
are common worldwide and the prevalence of allergic disease in industrialized 
countries is estimated to be 10-25%45.  In a study investigating allergic rhinitis in 
elite athletes, it has been reported that 30% of the control subjects experienced 
physician diagnosed disturbing allergic symptoms46.    It has also been documented 
that respiratory tract allergy, in particular allergic rhinoconjunctivitis is common in 
athletes, especially in elite athletes46-51.  Atopic illness was identified in 62% of the 
81 (63% of Olympic squad) athletes tested who represented South Africa during the 
Sydney Olympic Games, and of these athletes tested (11%) were found to be 
asthmatic49.    The prevalence of atopy (62%) in the South African Olympic squad is 
thus significantly higher than that in the general population but it is similar to the 
prevalence reported in Australian athletes.  Indeed, 56% of 214 elite Australian 
athletes tested for allergy before the Sydney Olympic Games gave a symptom 
history consistent with allergic rhinoconjunctivitis, 59% had a positive skin prick test 
to tested allergens and 21% stated that they had experienced asthma50.  A later 
study examining the patterns of allergic reactivity and disease in Olympic athletes 
reported a positive skin prick test in 56% of the athletes and 37% of the athletes 
reported having had allergic rhinoconjunctivitis48.  In a recent study, the prevalence 
of allergic disease in juvenile football players was documented as 34.5%52.  
However, this study was unfortunately of limited value due to its small sample size.  
As the symptoms of allergic respiratory tract conditions and the symptoms of URT 
infections overlap, the possibility that RTS in athletes are related to allergies needs 
to be considered.  Finally other physical factors, such as mechanical trauma of the 
airways due to high air flow rate during exercise, as a cause for RTS in athletes 
must be considered as possible mechanisms. 
25 
2.2.4. Dermatological conditions 
The epidemiology and prevalence of various skin diseases in athletes have been 
reported53,54.  Furthermore, infective skin disorders pose a risk of disease 
transmission amongst athletes.  Studies reporting the prevalence of Tinia Corporis 
in wrestling teams have found 24 to 77% of wrestlers to be infected53.  Herpes 
simplex in athletic populations has also been widely studied and the reported 
prevalence varies between 2.6% to 40.5% with a mean prevalence of 20%55.  The 
prevalence of impetigo is currently unknown.  Methicillin-resistant Staphylococcus 
aureus has however been cultured from 22% of wrestlers’ furuncles53.     
2.2.5. Central Nervous System 
Exercise and sport-related headaches are often induced by exertion.  The 
prevalence of sport-related headaches has been reported to be 35% in active 
university students56 and various headache syndromes have been described in 
athletes57-60.  The prevalence of the sport-related headache types in affected 
athletes have been reported as follows: effort / exertion headache (60%), post-
traumatic headache (22%), effort migraine (9%), trauma induced migraine (6%) and 
miscellaneous (3%)56,61.  The prevalence of benign exertional headache (defined as 
a bilateral, throbbing pain lasting 5 minutes to 24 hours, specifically provoked by 
physical exercise and not associated with any systemic or intracranial disorder) has 
been reported in (1%) of the general population62.  In division 1 National Collegiate 




migraine headaches has been reported to be 2.9%63.  In football no epidemiological 
studies have been published, describing the prevalence of headache syndromes. 
 
2.2.6. Gastrointestinal system 
 
It is well recognized that gastrointestinal complaints are common amongst athletes, 
especially endurance athletes.  Gastrointestinal symptoms in athletes64 and distance 
runners65,66 have been reviewed previously.  Upper gastrointestinal symptoms such 
as heartburn, epigastric pain, nausea, and vomiting are reported by 20-50% of 
endurance athletes67 and up to 50% of athletes during high-intensity exercise68.  The 
lifetime prevalence of GIT symptoms associated with running range from 20-83%65.  
No epidemiological studies have been published, describing the prevalence of GIT 




From the limited research describing the prevalence of medical conditions and 
illness in athletes, it can be concluded that medical conditions are common in this 
population.  The prevalence of reported conditions depends on the condition and the 
population described.  The majority of the current studies describe the prevalence of 
individual conditions in athletes and do not discuss the prevalence of “all” medical 
conditions in a cohort population.  The most common conditions reported in athletes 
are gastrointestinal complaints (83%), skin infections (77%), allergic conditions 




(23%).  Thus, only limited data are available regarding the prevalence of common 
medical conditions that may affect elite athletes.  More specifically, there are no data 
on elite footballers.  As pre-existing medical conditions may affect an athlete’s 
performance and unknown conditions may expose an athlete to a risk of 
complications, the documentation of medical conditions present in athletes will 
assist team physicians to identify risk patterns and to help develop pre-participation 
examinations (PPE) or periodic health evaluations (PHE) to improve medical care 
delivered to athletes. 
 
2.3. Incidence of medical conditions and illness in elite athletes during 




The incidence of medical conditions affecting athletes during elite international 
sporting events has been reported previously, but has not been well studied.  In 
particular, the incidence of general medical conditions and illness has not been 
reported in elite football players during international tournaments.  Major sporting 
bodies including FIFA, the IOC, FINA and the IAAF have published only limited data 
for medical conditions or illness during their major events.  These organizations 
have only recently added illness surveillance to their medical data collection during 
events.  Serious medical illnesses during elite sporting events such as the World 
Cup and Olympic Games are uncommon and such, mass participation sporting 
events have not been associated with an increased number of disease outbreaks69.  




pandemic influenza have highlighted the need for good surveillance strategies 
during international sporting events.  
 
2.3.2. Incidence if injuries reported by elite athletes and footballers 
 
As previously mentioned, the majority of the current literature addressing the health 
of elite athletes has focussed on the incidence of injuries only and has neglected the 
incidence of medical conditions. Football injuries have also been well reported on 
during previous international FIFA tournaments, including the FIFA 2006 World Cup 
in Germany25.  The FIFA Medical Assessment and Research Centre (F-MARC) 
began the study of injuries during the final rounds of the 1998 FIFA World Cup in 
France.  All subsequent tournaments organised by FIFA as well as the football 
tournaments during the Olympic Games in Sydney and Athens have been 
monitored26.  The incidence and nature of injuries in football is not the primary aim of 
this dissertation. Furthermore, F-MARC injury research methodology has been well 
reported elsewhere1,2,25,26, therefore football injuries will not be reviewed in this 
literature review.  However, injury epidemiology will be briefly discussed in chapter 4 
of this dissertation with reference to illness data that were collected.  The injury data 
will only be used to compare and highlight the relative importance of the medical 








2.3.3. The incidence of medical conditions and illness in elite athletes   
 
It is well established that various medical conditions and illnesses, especially 
respiratory tract symptoms, affect elite athletes while travelling to and competing in 
international competitions70-73.  These medical conditions most commonly affect the 
ear nose and throat, respiratory tract, dermatological system, central nervous 
system and gastrointestinal system70-74 but any of the body organ systems may be 
affected.  Elite athletes are not immune to any of the disease processes that may 
affect the general population.  A descriptive epidemiological study of college athletes 
found that 27% of the consultations were for medical problems, with respiratory tract 
(21% of the medical consultations) and dermatological (13% of the medical 
consultations) conditions being the most common problems encountered over a 2 
year period75.  Furthermore, there is some evidence suggesting that the risk of 
contracting certain medical conditions such as URT infections may be increased due 
to regular strenuous activity.  The most common systems involved will be reviewed 
individually in more detail. 
 
2.3.3.1. Cardiovascular system 
 
Sudden cardiac death (SCD) (defined as, a witnessed or unwitnessed natural death 
resulting from sudden cardiac arrest occurring unexpectedly within 6 hours of a 
previously normal state of health76) is the most significant cardiovascular event 
which may occur while participating in sporting activities.  The annual incidence of 
sudden death among high school and collegiate athletes ranges between 1 in 




death is reported to have reduced by 89% in screened athletes from 3.6 / 100 000 
person years (1979 – 1980) to 0.4 / 100 000 person years (2003 – 2004) with the 
rate of SCD in unscreened nonathletic population remaining unchanged77.  
However, in the 10 years from 2000 to 2010 there have been 40 reports of sudden 
death in professional footballers, one of which, a player (aged 26) who collapsed 
suddenly and died due to hypertrophic cardiomyopathy during the 2003 
Confederations Cup in France (www.in.reuters.com, www.wikipedia.org).  To date, 
no studies reporting the incidence of cardiovascular disease or sudden cardiac 
death in footballers have been published. 
 
2.3.3.2. Respiratory system 
 
There is evidence from previous studies that endurance athletes are prone to 
develop upper respiratory tract symptoms just prior to and in the 2 weeks after 
strenuous events4.5,8,40,78-80.  It is also known that athletes have a high prevalence of 
allergy and that travelling athletes are exposed to a variety of allergens at the 
venues at which they participate.  This may aggravate both acute and chronic 
allergies and reduce athletic performance in these athletes47.  Respiratory tract 
symptoms in elite athletes participating in events lasting a few weeks, such as the 
Olympic Games, are very common and account for a large portion of the medical 
complaints attended to by the team physicians responsible for the athletes 
health70,71.  Respiratory tract symptoms accounted for 36% of all the illnesses 
reported in a retrospective study of international footballers81 and 47% of the 




2.3.3.2.1.1. Seasonal influenza 
Seasonal influenza occurs worldwide, and constitutes a highly contagious 
respiratory illness.  Influenza will typically reach its peak in mid winter.  In South 
Africa, mid winter is in June and this was the period of the present study and also 
the 2010 FIFA World Cup.  It is well recognised that, due to air travel and high 
training loads, travelling athletes are prone to common viral infections including 
influenza.  Crowded living conditions, including those at mass sporting events such 
as the Olympic Games and World Cup football tournament, also potentially favour 
the spread of contagious diseases, such as influenza.  Influenza vaccination is 
currently recommended for any person wishing to protect themselves from the risk 
of contracting this infection, especially in industrial settings, where large-scale 
absenteeism could cause significant economical losses83.  It can therefore be 
recommended that athletes receive an annual influenza vaccination. 
2.3.3.2.1.2. Novel or Pandemic H1N1 “Swine” influenza 
The WHO declared the outbreak of novel H1N1 “swine” influenza a global pandemic 
on the 11th of June 2009, exactly one year before the opening match for the 2010 
FIFA World Cup tournament.  Fortunately, this disease did not prove to be highly 
virulent and no travel restrictions were imposed.  During the 2009 winter influenza 




were reported by the National Institute of Communicable Disease (NICD) in South 
Africa, with 91 laboratory confirmed H1N1 related deaths84.  The NICD reported 2 
peaks in the weekly number of influenza specimens tested (the first peak in week 24 
of 2009 and a second atypical peak in week 32 of 2009).  This second atypical peak 
was due to the novel H1N1 influenza outbreak85.  The northern hemisphere 2009-
2010 seasonal influenza vaccine did not incorporate the A/California/7/2009(H1N1) 
virus strain of the novel H1N1 virus.  However, the influenza vaccine for South Africa 
for 2010 did include this strain.  It was thus recommended that travellers to South 
Africa including the elite footballers receive a separate monovalent pandemic H1N1 
vaccine before travelling or consider influenza vaccination with the recommended 
southern hemisphere vaccine once in South Africa. 
 
2.3.3.3. Dermatological system 
 
Participation in sporting activities can result in various dermatological conditions the 
most common being skin infections.  These skin infections can be minor such as 
superficial fungal infections or more significant conditions such as Herpes simplex 
eruptions, which have been well documented55.  Furthermore, outbreaks of 
community-acquired methicillin-resistant Staphylococcus aureus skin infections, 
previously only recognized in hospital based patients, have also been reported in 
several sporting disciplines, including football, rugby, wrestling and fencing86,87.  
Such an outbreak was reported in 2003, where 5 of 58 (9%) of the St Louis Rams 
professional football team were affected88.  In 2004, a case report of a single football 
player with a methicillin-resistant Staphylococcus aureus abscess on his wrist, after 
a graze wound was sustained on the pitch was reported89.  Following these 




as being at a high risk for developing methicillin-resistant Staphylococcus aureus 
skin infections by the Centres for Disease Control and Prevention89.   Other 
dermatological problems include inflammatory conditions such as allergic dermatitis 
and neoplastic disorders including skin malignancies from over-exposure to the sun.  
Dermatological conditions in athletes have been reviewed extensively 
elsewhere53,90. 
   
2.3.3.4. Central nervous system 
 
The incidence of concussion has been well studied and reported in football91.  
However, no epidemiological studies have been published reporting on the 
incidence of other non-traumatic central nervous system conditions.  Jet lag 
following travel across multiple time zones has been associated with neurological 
complaints in athletes.  A high number of medical consultations were reported 
during the first week of travel to the Sydney 2000 Olympic Games, by the South 
African team, due to vague neurological symptoms, (headache, malaise and 
insomnia), and these were ascribed to possible jet lag70.  Jet lag is the result of a 
lack of synchrony of the normal body rhythms due to travelling over time zones, the 
main symptoms of which are tiredness, sleeping difficulties, mood changes and loss 
of concentration.  Although jet lag is not an illness and is of limited medical 
importance, the effects of jet lag may result in interpersonal conflict and poor 
sporting performance until the individuals have adapted to the new time zone.  
Furthermore, in a 1-year retrospective study of 852 German athletes, the risk of 
URTI was highest in endurance athletes reporting significant stress and sleep 
deprivation related to travel14.  Generally, those travelling in an easterly direction will 




of the day.  A case report of an elite rugby player travelling over numerous time 
zones and managing to play with distinction ascribes the good performance to 
appropriate travel advice and the selective use of medication such as melatonin and 
short acting sedatives92.  However, the World Health Organisation (WHO) does not 
recommend the use of melatonin but rather recommends the use of short-acting 
sedatives.  The routine use of such short-acting sedatives has been described by 
members of teams competing in the Super 14 international rugby competition93. 
 
2.3.3.5. Gastro-intestinal system 
 
Gastrointestinal complaints have been reported to account for up to 7% of the 
medical conditions reported by the participants of sporting events81,94.  However, 
gastroenteritis disease outbreaks may result in a significantly higher frequency of 
gastrointestinal complaints.  During the 2006 FIFA World Cup in Germany, 8 
members of the Croatian team reported symptoms of a suspected viral gastro-
enteritis on the 1st day of the tournament69.  Travellers’ diarrhoea was also reported 
in 20% of the 122 (81 athletes and 41 officials) team members travelling to the 
Youth Commonwealth Games in India95.  The GIT symptoms with the highest 
incidence (occurrence / 1000 participant hours) in endurance sports have been 
reported as follows: urge to defecate (74), abdominal cramping (48) and heartburn 
(32)96.  It has also been reported that running and the running leg of triathlon are 
characterized by a particularly high risk of developing lower GIT symptoms96.  To 






2.3.3.6. Other infections: Glandular fever 
 
Infectious mononucleosis is common and by the age of 30, 90% of the general 
population has been exposed to the Epstein-Barr virus97.  An outbreak of infectious 
mononucleosis has been reported in athletes and includes a report of 10 cases, 
confirmed by Epstein-Barr virus serology, in a squad of 24 swimmers in a single 
season28.  A concern for athletes diagnosed with infectious mononucleosis is the 
association of spontaneous or traumatic rupture of the spleen and this has been 




From the limited research describing the incidence of medical conditions and illness 
it can be concluded that 27-69% of consultations in athletes seen by a team 
physician during sports events are due to medical conditions.  The most common 
conditions reported in athletes are upper respiratory tract infections (47%), 
gastrointestinal symptoms (20%) and skin infections (13%).  Only limited data 
discussing the incidence of common medical conditions that may affect elite athletes 
exists and it appears that there is only one study describing medical conditions 
amongst elite footballers.  The incidence of illness may be at least as common as 
the incidence of injury and thus may be an important contribution to the burden of 
disease.  Many of these conditions may have a profound effect on an athlete’s 
performance and to assist team physicians and event organisers with optimal 









Elite football players travel to different locations throughout the world to participate in 
events lasting from a few days to weeks.  These events are characterized by regular 
strenuous games and training sessions between games.  Many matches are also 
scheduled at night causing sleep disturbances.  Players may be exposed to differing 
environmental conditions such as extremes of temperature, humidity, adverse 
atmospheric pollution, aeroallergen exposure and dietary changes.  Furthermore, 
athletes breathe a higher volume of air than non-athletes and are thus exposed to a 
greater volume of respiratory irritants which may amplify an inflammatory response 
in their airways45.  It has been suggested that exposure to these different 
environmental conditions may also increase the risk of medical conditions such as 
GIT illness, RTS, URTS and other illnesses during sports participation50.  Finally, 
players travelling between the northern and southern hemispheres are exposed to 
different pathogenic organisms including seasonal viral influenza strains which may 






2.4.2. Medical conditions associated with travel to international sports 
events 
Whilst there are numerous studies describing general travel health and medical 
conditions at large sporting events such as the Olympic and Commonwealth 
Games72,93,99-101, to date no studies have been published which have investigated 
the travel related health issues pertaining to elite footballers or FIFA World Cup 
tournaments.  However, a recent paper has discussed communicable disease risks 
and advice for visitors to the South Africa 2010 FIFA World Cup102. 
It is well established that various medical conditions and illnesses, including 
respiratory tract symptoms, affect elite athletes while travelling to and participating in 
international competitions70,71.  During the Cricket World Cup held in South Africa in 
2003, 47% of the 90 patient presentations managed by the medical committee were 
due to illnesses, the other 53% were due to injuries94.  The incidence of 
consultations in this Cricket World Cup was reported as 1.6 consultations per match, 
with upper respiratory tract infections being the most common medical problem 
reported.  29% of the illness presentations were reported to be due to assumed 
infection as these diagnoses were based on clinical evaluation only and not 
confirmed by laboratory investigations. 
Of the 1804 athletes managed by the multipurpose medical facility at the 1996 
Olympic Games, 868 (48%) were managed for non-injury related illness103.  During 
the Sydney Olympic Games, 69% of all the consultation reported by the South 




most commonly affected the ENT, respiratory tract and gastro-intestinal system70.  
The New Zealand medical team, supporting their athletes at the 2000 Sydney 
Olympic Games also reported a high incidence of respiratory tract infections 101 
(17%) of the 606 consultations, whilst in total, 308 (47%) of the consultations were 
reported as medical and 345 (53%) due to injuries104. 
 
The results of 4 studies describing the injury and illness data from elite sporting 






Table 2.1.:  The frequency (n = number of consultations) and 
percentage (%) of all formal medical consultations in elite athletes 
participating in tournaments / competitions [2000 Olympic Games 
(South African and New Zealand teams), 2004 Olympic Games (South 
African team), the 2003 Cricket World Cup (All teams) and the 2007 











































Injuries (345) 53%  (108) 31% (72) 40% (48) 53% (117) 67% (102) 73% 
Illnesses (308) 47% (240) 69% (108) 60% (42) 47% (57) 33% (38) 27% 
Ear nose & throat 3% 18% 13% 0 4.5% 4% 
Respiratory 18% 16% 8% 14.5% 9% 9% 
Neurological 1% 16% 4% 3% 2% 2% 
Gastrointestinal 4% 6% 6% 7% 7% 2% 
Dermatological 7% 2.5% 16% 8% 3.5% 3% 
Urological 0.5% 2.5% 0.5% 3% 0 0 
Psychological 0 2% 3% 0 3.5% 3.5% 
Cardiology 0.5% 1% 3% 0 0 0 
Ophthalmology 2% 0.5% 0.5% 3% 0 0 
Other 11% 4.5% 6% 8.5% 3.5% 3.5% 





When evaluating the data listed in table 2.1., the following comments need 
consideration. 
 
Firstly, the data for the Olympic Games, Cricket World Cup and Trinidad and 
Tobago football teams all reflect the number of consultations for both players and 
officials.  Data for the medical consultations of the Trinidad and Tobago team 
players only is also listed separately in the table.  It may be assumed that team 
officials will have a lower incidence of injuries as they are not participating in the 
sporting competition and thus a higher proportion of illnesses than injuries will be 
recorded if the data from officials is included.  Furthermore a significantly higher 
frequency of GIT consultations was recorded in the officials of the Trinidad and 
Tobago football team, when compared to the players. 
 
Secondly, follow-up consultations should not be recorded when determining the 
incidence of an illness or injury.  No mention is made in these studies of whether 
some of the illness consultations were follow-up visits or whether only new illnesses 
were recorded.  If follow-up consultations have been recorded, the data are difficult 
to interpret.  The New Zealand Olympic medical team reported 345 injuries and 308 
illnesses but only 606 consultations as some consultations involved more than one 
presenting problem.  The other studies did not discuss how they reported more than 
one complaint in a consultation. 
 
Finally, with the exception of the New Zealand team, the ratio of injuries to illnesses 
is 60:40 for the Olympic Games (a multi-sports event), 50:50 for the cricket World 




incidence of injuries is expected to be higher than that found in multi-sports events 
such as the Olympic Games.  A similar finding has previously been reported in a 
study evaluating injuries in all the team sports during the 2004 Olympic Games 
where the overall incidence of injuries was reported as 0.8 injuries per match (multi-
sport) and the incidence of injuries in football only was 2.4 injuries per match1. 
 
From the current studies it is difficult to compare the data directly as the reporting of 
illnesses differ. The New Zealand Olympic team reported (11%) of the consultations 
as “other” (gynaecological, dietary, other infections, allergy, insomnia, fatigue and 
notifications).  Many of these consultations could have been diagnosed more 
accurately and classified in an appropriate coding system such as the ICD coding 
system.  In the Cricket World Cup study no ENT conditions were recorded and 
14.5% respiratory conditions.  As 14.5% may be considered higher than expected it 
may be assumed that a number of the consultations recorded as respiratory may in 
actual fact have been of ENT origin.  The definition and classification of respiratory 
tract and ENT illness needs clarification and needs to be addressed more accurately 
in future studies.  This will assist physicians to accurately classify URT symptoms as 
either ENT or respiratory conditions and thus provide essential data to help plan 
better medical care for teams.  Combining the respiratory and ENT frequencies for 
the various studies gives comparable results with the exception of the South African 
report from the Sydney Olympic Games.  The author of the Sydney Olympic Games 
study suggested a higher frequency of ENT and respiratory consultations due the 
high prevalence of atopic illness in the athletes and a high incidence of seasonal 
allergic illness associated with high aero-allergen counts during this spring-time 





During the Sydney Olympic Games the South African team reported a high 
frequency of neurological complaints (16%)70.  The authors of this paper ascribe the 
high frequency of vague neurological complaints to jet lag as the majority of the 
athletes reported these symptoms in the first week after travelling to Sydney.  
 
A higher frequency (16%) of dermatological problems was recorded during the 
Athens Olympic Games71.  The authors of that study attributed the high frequency of 
dermatological conditions to 1) a high frequency of fungal infections in the hot and 
humid weather conditions experienced in Athens during the Olympic Games, and 2) 
to a high frequency of ant or other insect bites to athletes in and around the Athens 
Olympic village. 
 
From the above data it is evident that the medical (non-trauma related) conditions 
reported by the participants during various elite international sporting events account 
for a significant volume of the consultations that the team physician will need to tend 
to.  Furthermore, the pattern of conditions reported is consistent through various 
sporting codes.  It is also evident that specific travel related factors such as jet lag 
and environmental conditions such as aero-allergens can influence the pattern of 
diseases encountered.  It is thus essential that team physicians familiarize 
themselves with the teams travel plans and competition venues environment when 





2.4.3 Other diseases and vaccinations 
Travel related diseases that can be highlighted as potential threats include polio, 
hepatitis A, hepatitis B, meningitis, measles, typhoid and cholera.  As there is 
currently a resurgence of measles in developed countries, including South Africa, 
such vaccine preventable diseases cannot be ignored.  Measles was recently 
highlighted, and this vaccine was the only vaccine recommended for the UEFA 
EURO 2008 football championships tournament that was held in Austria and 
Switzerland105.  Attention to routine travel related vaccinations, including Hepatitis B, 
specifically for contact sport participants, including footballers has also been 
recommended72,93.   
The prevention of illness is important to help limit both morbidity and mortality.  In 
elite athletes, disease can also have a significant impact on an athlete’s ability to 
participate resulting in financial losses.  Vaccination is one mechanism to help 
prevent the spread of disease and this has been recommended for athletes in 
previous studies28.  Recommended adult immunisation schedules are updated and 
published regularly106.  Recommended immunisations against diseases that may 
affect elite athletes include hepatitis, influenza and meningitis.  To date, no studies 
have included a history of vaccinations in elite athletes.  The prevalence of previous 
exposure and immunity to diseases such as Hepatitis A and B are unknown in the 
elite athletic populations and footballers.  Furthermore, the incidence of travel 





Athletes who may be prone to respiratory tract infection due to the stress of training, 
participation and travel associated with sporting competition should ensure 
appropriate influenza vaccination.  As Influenza is a debilitating disease with a rapid 
onset, athletes cannot afford to ignore this vaccine preventable condition.  It is thus 
recommended that all participants, officials and supporters attending large 
international sporting events be vaccinated with the current seasonal influenza 
vaccination.  Such recommendations have previously been advised by the World 
Health Organization for large sporting events such as the 2000 Olympic Games in 
Sydney, Australia104.  As many athletes travel from one hemisphere to the other, 
consideration must be given to having a second Influenza vaccination with the 




Malaria is the most common life threatening travel related disease that is associated 
with travel to the tropical regions of the world107.  This is a protozoal parasitic 
infection caused by 1 of 5 Plasmodium species, P. falciparum (common to Africa), 
P. ovale, P. malaria, P. vivax or P. knowlesi.  The parasite is transmitted to humans 
through the bite of the female Anopheles mosquito.  The greater South Africa is 
Malaria free and there was no risk of contracting Malaria while staying in the host 
cities or attending matches during the 2009 Confederations Cup.  Athletes visiting 
other areas as tourists, or for the purpose of training camps, may be exposed to 
malaria.  Specific travel recommendations may be considered for each separate 
travel destination.  The north-eastern regions of South Africa are Malaria endemic 
and preventative measure must be utilised when visiting those areas.  




May but personal protective measures must always be taken by those who plan to 




Schistosomiasis (Bilharzia) is a trematode infection caused by the S. mansoni, S. 
heamatobium or S. intercalatum species and occurs over much of the eastern half of 
South Africa.  The risk of this tropical infection to travellers and athletes has been 
highlighted in several published articles, and documented particularly in 
Zimbabwean triathletes107,108.   All travellers should be advised to avoid swimming or 
wading in fresh water lakes and streams in high risk areas.  
 
2.4.3.3. Tick-bite fever 
 
African tick bite fever is a tick-borne Rickettsial infection which is endemic 
throughout South Africa.  It occurs more commonly in the summer but can occur 
throughout the year.  Published GeoSentinal data has reported the spotted fever 
group (rickettsiosis) as the most predominant cause of systemic febrile illness 
reported in South African travellers.  Furthermore, these travellers were likely to 
present with rickettsiosis if they were male, travelling as a tourist and visited the 
country between June and September109.  The incubation period of the disease is 5-
7 days and thus a player may present with non-specific symptoms of fever, 
headache, joint pain and a rash after returning home.  Possible exposure to ticks 




outbreak of African tick-bite fever in 13 (4%) of 331 French participants (athletes and 
officials) returning home after an Eco-challenge in South Africa has previously been 
reported110.  
 
2.4.3.4. Viral hepatitis 
 
There is a risk of hepatitis virus transmission during sports participation.  Outbreaks 
of both Hepatitis A and Hepatitis B have been documented in athletic populations.  
An outbreak of Hepatitis A affected 90 members of the College of Holy Cross 
football team due to an infected water supply111 and an outbreak of Hepatitis B has 
been reported among a group of high school sumo wrestlers in Japan due to an 
asymptomatic carrier112.  Furthermore, the prevalence of Hepatitis B in the team 
members of the Okayama University American football team in Japan reported over 
19 months was (20.4%), significantly higher than that of other students at the 
university (1.8%).  One of the team members was reported to be an asymptomatic 
carrier113.  Athletes involved in team sports have a prolonged close contact exposure 
to team mates and share food, eating utensils or sporting equipment.  Therefore 
they are at greater risk than individual sport athletes114.  The current prevalence of 
hepatitis in athletic populations is not known and thus the risk of transmission cannot 
be estimated115.  It is though a general recommendation that vaccination against 
both Hepatitis A and Hepatitis B be considered for all non-immune “at risk” 
individuals.  Hepatitis B transmission is by blood products and sexual contact and 






2.4.3.5. Human immunodeficiency virus (HIV) 
 
The risk of Human Immunodeficiency Virus (HIV) infection during sporting 
participation has in theory been calculated to be extremely low116.  However, HIV 
and other sexually transmitted diseases are health risks that need to be considered 
in elite athletes as “off the field” exposure to these diseases needs to be limited.  It 
has been reported that 2.4% of travellers to South Africa report morbidity due to 
sexually transmitted diseases109.  Athletes participating in South Africa must be 
made aware of the risks of contracting HIV and other sexually transmitted diseases 
(South Africa has one of the highest HIV seroprevalence figures in the world, 18% in 
the adult population and 29.3% of pregnant woman109) and they need to avoid risky 




Meningococcal disease is not common in South Africa, but localised sporadic 
outbreaks do occur usually between May and October.  Of concern for large football 
events is the possible exposure of footballers from Africa to the “meningitis belt” 
which runs across central Africa from Senegal to Ethiopia.  These players may pose 
a risk as there may be asymptomatic carriers of meningitis and thus exposing other 
players to the disease.  Vaccination with the quadrivalent polysaccharide vaccine is 
not legally required for entrance to any country other than Saudi Arabia during the 
Hajj pilgrimage.  This vaccination though can be considered and motivated when 
considering elite football tournaments as they can be viewed as mass gathering 
events with potential exposure from endemic areas. 
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2.4.3.7. Cholera 
The 2008/2009 Cholera epidemic in neighbouring Zimbabwe did not spread to 
South Africa other than the direct bordering areas and no travel restrictions were 
necessary.  Routine cholera vaccination is not an international requirement by the 
WHO or South African officials.  Due to the low effectiveness of the current oral 
cholera vaccine, vaccination is not recommended or required for routine travel. 
2.5. Post-event-illness in the returning athlete 
Team physicians need to consider tropical infections, especially malaria when 
players present with a febrile or any “flu-like” illness after having travelled to the 
tropical and or malaria endemic areas of the world.  Effective detection of a post-
event Leptospirosis disease outbreak amongst participants of the Eco-Challenge-
Sabah 2000 multisport endurance race held in Malaysian Borneo has been 
reported.  These athletes presented with febrile illness, chills, headache and 
myalgia117.  Travellers are exposed to various pathogens (viral, bacterial, fungal and 
parasitic) and they can return within the incubation periods of many diseases.  There 
may be diagnostic difficulties in confirming the aetiology of a disease in a 
symptomatic patient with a history of travel.  The possible unfamiliarity of a physician 
to disease that is not endemic to the area in which they practice, requires a stepwise 
approach to the management of fever in the returning traveller118.  An early 
diagnosis and appropriate prompt treatment are essential in the successful 
management of malaria.  The most common tropical illnesses in South Africa that 




have already been reviewed107.  It is essential to inform health care workers about 
previous travel should an illness occur once at home.   
 
2.6. Summary and conclusion 
 
There is a growing interest in medical conditions and illness in elite athletes.  The 
current body of knowledge expands with every study published.   
 
The most important findings from this review are that, 1) medical conditions and 
illness in elite athletes, and in particular in elite footballers have not been studied 
extensively, 2) there is a need for further studies to investigate medical conditions 
and illness in elite athletes and these aspect of elite footballers’ health, 3) the natural 
immunity and vaccination status of elite athletes has not been studied and 4) travel 
and environmental factors have an effect on the medical conditions reported in elite 
athletes. 
 
Furthermore, the reporting of medical conditions and illness and studies 
investigating the pattern of medical illnesses in athletes should be standardized.  
Particularly, the definition of illness, respiratory tract symptoms and ENT symptoms 
need to be clarified.  Future studies investigating medical conditions and illness in 
athletes, particularly those reporting data from competitions need to report data 
collected for officials and players managed separately.  This will allow for the 
distinction to be made between the incidence of medical conditions and illness in the 




accurately determined.  To calculate the incidence of a condition, the first 
consultation needs to be documented and recorded as such.  Follow-up 
consultations must also be recorded separately to determine the burden of disease 
on the medical staff.  Team physicians responsible for the care of sporting teams 
are also responsible for the medical care of the team officials.  For research 
purposes it is not only useful to determine the incidence of medical conditions in 
participating, athletes but also to determine the total work load of the medical team 
relating to care of officials and follow-up consultations which are often as time 
consuming as first consultations.  Furthermore, how the researcher managed the 
reporting of multiple medical problems in one patient also needs to be discussed.  In 
the recent paper reporting injuries and illnesses during the 2010 Winter Olympic 
Games, only the most severe injury / illness was recorded if multiple body parts 
were injured during the same incident or if different body parts were affected by 
illness119.  This method has previously been described in a football injury data 
collection consensus statement120. 
 
Finally, the reporting of medical condition and illnesses experienced in athletes will 
contribute to the planning of events and the medical management of both footballers 






The prevalence of medical conditions and illness in elite 
football players: 




It has been documented that the most common medical conditions in athletes affect 
the upper respiratory tract, gastrointestinal systems and the skin103,121.  However, 
the prevalence of medical conditions and illness has not been investigated in elite 
professional football players. Furthermore, an elite international football tournament 
such as the Confederations Cup potentially exposes the players involved to 
competition in a foreign environment and this may increase the risk of developing 
medical conditions and illness whilst participating in such tournaments. 
 
The aim of this study was to document the prevalence of medical conditions and 
illness in elite football players participating in the FIFA Confederations Cup held in 
South Africa in 2009. 








3.2.1. Type of study 
 




The UCT/MRC (University of Cape Town / Medical Research Centre) Research Unit 
for Exercise Science and Sports Medicine, together with F-MARC (FIFA Medical 
Assessment and Research Centre) (Switzerland), conducted this study to determine 
the prevalence of medical conditions and illness in the elite football players who 
participated in the 2009 Confederations Cup tournament.  The research protocol 
was approved by the University of Cape Town Health Sciences Research and 
Ethics Committee (REC REF: 159/2009) (Appendix 2) and the Institutional Review 
Board of F-MARC. 
 
All 184 elite male football players participating in the 2009 FIFA Confederations Cup 
football tournament were considered as potential subjects for this study.  Prior to the 
start of the tournament, information regarding all the components of the planned 
research study was made available through F-MARC to the eight team physicians 
that were to accompany each countries players participating in the tournament.  The 




nature of the research study to each player in their respective teams.   These 
details, as well as all the potential risks and benefits of the study, were explained to 
the players through a detailed subject information sheet (Appendix 3).  Once 
informed, the potential subjects were invited to participate in the study and those 
that completed an informed consent form (Appendix 4) were included in the study. 
 
3.2.3. Pre-competition medical history questionnaire 
 
Once written informed consent was obtained, all the participating players were 
asked, together with their team physicians, to complete a detailed medical history 
and training questionnaire (Appendix 5).  The main components of this 
questionnaire have been previously validated during similar studies on Ironman tri-
athletes and ultra distance runners (2000, 2001, 2006 and 2007 Ironman research 
studies REC005/2000, 099/2001, 425/2005 and 007/2007)40,49,122.  These 
components of this questionnaire were appropriately modified for use in elite football 
players. 
 
In order for all the collected data to remain anonymous, a system of coding for each 
player and team was used and the personal details of each individual player were 
not included on the questionnaire. Each team was allocated a random number from 
1 to 8 and each player a random number from 1 to 23.  Only the team and player 
code numbers were listed on the questionnaires. 
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The main focus of the medical questionnaire was on current and past history of 
medical conditions.  The medical questionnaire consisted of various sections and 
included details of each of the participant’s medical, training and surgical history 
including respiratory tract illnesses, atopy and exercise associated muscle 
cramping. 
The following sections were included in this study: 
Section A, Basic player demographic details (including age, height, weight) 
Section B, Training history 
Section C, Medication, supplement and life-style history 
Section D, Family history of asthma and allergies 
Section E, Personal medical history including; 
history of flu symptoms, 
history of allergy symptoms, 
history of asthma, 
history of exercise associated muscle cramping, 
history of gastro-intestinal symptoms, 






3.2.4. Statistical analysis of the data 
 
All data from the questionnaires were entered into Excel spreadsheet format 
(Microsoft Office 2007).  The data were analysed using standard statistical methods.  
All numerical data are represented by the mean ± standard deviation (SD), with the 
number of subjects (n), in parenthesis.  Categorical data are expressed as 
percentages or ratios. The statistical methods applied were frequencies, cross-




3.3.1. Response rate 
 
One of the teams declined to participate in this research project.  Therefore, only 7 
of the 8 teams (87.5% of the teams representing 161 potential subjects from the 7 
teams) participated in this research study.  Of the 161 potential subjects for the 
study, 138 (85.7%) completed the medical questionnaires.  The response rate for 
the return of the medical history questionnaires from each individual team is 






Table 3.1.: Medical history questionnaire response rates for the teams 
participating in the 2009 Confederations Cup, (number of players and 
percentage per team) 
Team number a Player response, 
(number of players) 
Player response per 
team (%) b 
1 22 96% 
2 21 91% 
3 23 100% 
4 13 56% 
5 17 74% 
6 23 100% 
8 19 83% 
Average response 17.25 85.7% 
a : Team number 7 declined to participate 
b : Calculated as % players per team (23 players in each team) 
 
3.3.2. Player characteristics 
 
The mean age, height, body weight and dominance (upper and lower limb) of the 
138 players who participated in the study is depicted in table 3.2.  The majority of 
the players were right dominant (123 of the players reported right hand dominance 






Table 3.2.: Player demographics and dominance (upper and lower limb) 
Age (yrs) 26.3 ± 3.5 
Height  (cm) 181.9 ± 6.2 
Weight (kg) 77.4 ± 7.3 
Upper limb dominance (% players)  (right/left/both)  90%, 9%, 1% 
Lower limb dominance  (% players) (right/left/both)  79%, 13%, 8% 
Data are expressed as mean and standard deviations (SD) of frequency (% players) 
 
The number of players, in each of the various field positions, was reported by the 
players as follows: Goal keepers 17 (12.3%), defenders 42 (30.4%), midfielders 42 
(30.4%), strikers 27 (19.6%) and those in unspecified position were 10 (7.3%).  
 
3.3.3. Pre-competition training history 
 
3.3.3.1. Pre-competition training history (15 weeks before tournament) 
 
During the 15 week pre-competition period the players reported training 4.8 ± 2.2 
days per week (mean ± SD) with a total of 11.5 ± 6.9 hours of training per week 
(mean ± SD).  Ninety six (70%) of the players correctly reported their pre-
tournament training history, completing both the volume and percentage of time 
spend performing various training types as was requested.  Twenty two (16%) of the 
players, all from the same team, did not report any pre-tournament training.  Twenty 




training time spent performing the various training activity types.  It was reported by 
the players that 0.5% of their training time was spent performing other activities. 
 
3.3.3.2. Pre-competition training history (2 weeks before tournament) 
 
The pre-tournament training section of the medical questionnaire, investigating the 
training load in the period 2 weeks prior to the 2009 Confederations Cup was 
completed by 128 (93%) of the players.  The pre-tournament training history data 
was incomplete in 10 (7%) of the players and 20 (14%) of the players neglected to 
report the percentage of their training time spent performing the various types of 
training activities. 
 
The average number of reported days per week on which the players trained during 
the 2 week period before the tournament was 6.1 ± 1.7 training days per week, with 
an average of 13.6 ± 5.4 hours of training per week reported.  This constitutes an 
increase of 1.3 days per week compared to the 15 week pre-competition period 
where 4.8 ± 2.2 days per week of training were reported.  Accordingly, the average 
number of hours of training per week, 2 weeks prior to the tournament increased by 
2.1 hours per week from 11.5 ± 6.9 hours per week to 13.6 ± 5.4 hours per week.  
The majority (68%) of the reported training time was spent performing football 
training, the percentage of time spent on football training also increased from 63% to 
68% in the 2 week period prior to the tournament.  Of note, time spent on flexibility 
also increased marginally (0.9%) in the 2 week period prior to the tournament but 
strength and endurance training reduced.  It was reported that 0.8% of the training 




other training activities was not specified. The reported percentage training time 
spend by the players performing different types of training activities during the 15 
and 2 week pre-competition time periods, is depicted in figure 3.1.   
 
 
Figure 3.1.: Reported percentage of training time spent by the 
participating players on different training activity types in the 15 weeks 

































The players reported that their football training affected their social life as follows: 
no effect in 55 (39.9%), 
fair or moderate effect in 50 (36.2%), 
and significant effect in 32 (23.2%). 
There were missing data in 1 player (0.7%). 
3.3.4. Medication, supplements and life-style history  
In this study 4 (3%) of the 138 players were current smokers (having smoked for an 
average of 8.5 years).  These players reported smoking an average of 7 cigarettes 
per day.  Three players (2%) were ex-smokers, having stopped for an average of 3 
years and 131 players (95%) never smoked.  Fifty eight players (42%) reported 
alcohol use with an average reported use of 2.6 glasses of beer per week, 1.3 
glasses of wine per week and 0.2 units of spirits per week. 
In this study, only 11 players (8% of the 138 players) reported the use of medication. 
The most frequently reported type of medication used was for asthma and allergies, 
followed by the use of anti-inflammatory medication.  In contrast, 72 (52%) of the 
138 subjects reported the use of either supplements and or vitamins.  The reported 
use of the various classes of supplements and vitamins by the players in this study 




Table 3.3.: Reported use (expressed as number and % players) of 
vitamin and supplement use in the players participating in the 2009 
Confederations Cup 
Supplements Number (n) of players % players 
Multivitamin supplements 59 43 
Carbohydrate supplements 32 23 
Anti-oxidant supplements 28 20 
Protein supplements 28 20 
Creatine supplements 6 4 
Caffeine supplements 2 1.4 
Fat cutter supplements 1 0.7 
Immune boosters 1 0.7 
Other supplements 9 7 
   
 
Of the 9 (7%) players reporting supplements used, listed as other supplements, the 
joint supplements (glucosamine and chondroitrin) were the most commonly used 









3.3.5. Family history of asthma and allergies 
 
A family history of atopy (either asthma or general allergies) was reported by 20 
(14%) of the 138 players.  Fourteen players (10%) reported a family history of 
asthma and 12 players (9%) reported a family history of allergy.  Six players (4%) 
reported a family history of both asthma and allergies. 
 
A family history of a father or a brother with atopy was reported by 35% of the 
players reporting a positive family history of allergies.  A family history of a mother or 
sister with atopy was reported by 25% and 20% of the players reporting a positive 
family history of allergies respectively.  A family history of a grandfather or 
grandmother with atopy was reported by 10% each of the players reporting a 
positive family history of allergies and 5% of the players reporting a positive family 
history of allergies, reported atopy in their children. 
 
3.3.6. Pre-competition respiratory tract symptoms (RTS)  
 
A total of 12 players (8.7%) reported RTS in the 6 week period before the 
tournament and 7 players (5.1%) reported RTS in the 1 week prior to the 
tournament.  The nature of the RTS experienced by the players participating in the 







Figure 3.2.: The frequency of different RTS (expressed as % players 
with symptoms reported by the players 6 weeks and 1 week prior to the 
tournament) reported by the players participating in the 2009 
Confederations Cup 
 
3.3.7. Allergy symptom history 
 
A total of 27 (19.6%) of the players reported having suffered at some time from 
allergic symptoms (including allergic rhinitis (hay fever), allergic sinusitis, allergic 
asthma, skin allergies, allergic conjunctivitis, a past history of allergy to medication 
or plant material or animal material).  The average number of years of suffering from 
allergic symptoms was reported as 5.7 ± 4.0 years.  A total of 21 (15.2%) of the 
players reported a history of respiratory tract allergy.  The type of allergy reported 





































Table 3.4.: The prevalence (number of players with % in brackets) of 
self reported allergy, current and previous symptoms and medication 
requirements in the players participating in the 2009 Confederations 
Cup  









Allergic rhinitis 9 (6.5%) 4 (2.9%) 4 (2.9%) 
Allergic sinusitis 8 (5.8%) 0 3 (2.2%) 
Asthma 4 (2.9%) 5 (3.6%) 3 (2.2%) 
Skin allergy 4 (2.9%) 2 (1.4%) 1 (0.7%) 
Allergic conjunctivitis 4 (2.9%) 2 (1.4%) 1 (0.7%) 
Allergy to plant material (exposure) 10 (7.2%) 1 (0.7%) 5 (3.6%) 
Allergy to animal material (exposure) 8 (5.8%) 2 (1.4%) 2 (1.4%) 
Allergy to food (consumption) 3 (2.2%) 3 (2.2%) 1 (0.7%) 
Allergy to medication 2 (1.4%) 0 1 (0.7%) 
 
 
The reported current allergy medication use by the subjects (% of all subjects) was 
anti-histamine tables (2.9%), corticosteroid cream (1.4%), inhaled (nasal spray) 





The prevalence (% players) with current allergy symptoms is depicted in figure 3.3.  
None of the players reported headache, fatigue or poor sleep as symptoms 
associated with their allergies. 
   
 
Figure 3.3.: Frequency of allergy symptoms (expressed as % players 
experiencing symptoms) reported by the players participating in the 
2009 Confederations Cup  
 
3.3.8. Asthma history   
 
The prevalence of asthma was reported as 4.3% (6/138 subjects) and the mean 
number of years of having suffered from asthma symptoms was 12.5 ± 3.6 years.  
Two players (1.4%) reported that they experience exercise induced asthma 






















during exercise and 1 player (0.7%) reported that he experiences asthma symptoms 
at any time but not during exercise.  The diagnosis of asthma was made by a doctor 
taking a medical history and performing an examination alone in 3 players (2.2%), 
while 4 players (2.9%) reported having had standard lung functions performed to 
confirm the diagnosis.  Two players (1.4%) performed an exercise challenge lung 
function testing to confirm the diagnosis, 1 player (0.7%) performed a metacholine 
challenge test and 1 player (0.7%) performed an eucapnic hyperventilation test to 
confirm the diagnosis of asthma.  No players reported other methods of asthmatic 
diagnostic testing performed. 
The frequency of day time and night time asthma symptoms experienced by the 4 
players reporting asthma symptoms was as follows: 3 players experienced asthma 
symptoms less than twice a week and 1 player experienced asthma symptoms 2 to 
4 times per week both during the day and at night respectively.  No players reported 
experiencing asthma symptoms more than 4 times per week and no players 
experienced continuous symptoms.  Four players (2.9%) reported less than 1 
episode of exercise related symptoms per 10 exercise sessions and 2 players 
(1.4%) reported 2 to 3 episodes of exercise related symptoms per 10 exercise 
sessions.  No players reported a higher frequency of exercise related symptoms.  
None of the player’s who reported that they suffer from asthmatic symptoms, 
reported that they had required hospital admission for the management of their 
asthma in the preceding 12 months.  The most common asthma symptoms reported 
by the players were wheezing (2.9%), a tight chest (2.1%), dyspneoa (2.1%) and a 
dry cough (0.7%).  None of the players reported chest pain or reported other 




The use of asthma medication was reported as follows (% players): salbutamol 
(bronchodilator) inhaler (2.9%), cortisone inhaler (1.4%), salmeterol (bronchodilator) 
inhaler (0.7%), terbutaline (bronchodilator) inhaler (0.7%) and a corticosteroid and 
bronchodilator combination inhaler (0.7%).  No players reported the use of fenoterol, 
formoterol, ipratropium, tiotropium or other inhalers.  Furthermore, no players 
reported the use of corticosteroid, bronchodilator or leukotrine antagonist tablets, or 
other medication.  Two players reported daily use and 2 players reported use of 
medication only before exercise while 1 player reported use as needed.  The 
average time that the players reported using medication before exercise was 12.5 
minutes.  It is of interest to note, of the 6 players reporting current asthma and the 
use of asthmatic medication, 2 reported not having a therapeutic use exemption 
from their National Anti-doping organisations or sporting federation. 
 
3.3.9. Exercise associated muscle cramping history 
 
The lifetime prevalence of Exercise Associated Muscle Cramping (EAMC – defined 
as suffering from painful involuntary muscle contractions during or immediately or 
within 6 hour after exercise123), was reported by 46.4% (64) of the players.  The 
average number of years of suffering from EAMC was 3.5 ± 3.6 years.  The 
retrospective annual incidence (% players who suffered from muscle cramping in the 
previous year) of EAMC was 39.9% (55 players). 
 
Forty episodes of EAMC were reported in the last 10 matches played by 27 of the 
players (an average of 1.5 ± 1.0 episodes of EAMC player per 10 matches).  
Therefore, episodes of EAMC were reported in 15% of the matches played.  Sixteen 
68 
players reported 26 episodes of EAMC during their last 10 training sessions (an 
average of 1.6 ± 1.0 episodes of EAMC per affected player per 10 training sessions.  
Therefore, episodes of EAMC were reported in 16% of training sessions. 
The prevalence (% players reporting EAMC) of training that was associated with 
EAMC was reported as follows: football training (81%), running in (25%) and weight 
training (4%).  No players reported muscle cramping during other forms of exercise. 
The self-reported most successful treatment for EAMC is depicted in figure 3.5.  The 
majority (87.5%) of the players reported stretching as a successful method to relieve 
muscle cramping and this was followed by drinking fluid (78%), massage (55%) and 
rest (28%).  The use of salt, magnesium and ice were reported as successful 
methods for the treatment of muscle cramps in (16%), (9%) and (6%) of the players 
respectively. 
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Figure 3.5.: Self-reported treatment modalities (as % players with 
EAMC) which relieve EAMC  
Of the 64 players reporting EAMC 5 players did not complete the onset of EAMC 
section of the questionnaire.  The majority (76%) of the players reporting EAMC, 
reported that they usually first experience muscle cramping during the 4th quarter of 
training or matches.  This was followed by the EAMC after sessions (18%).  No 
players reported an onset in the 1st quarter and (2%) reported the onset of EAMC in 
the 2nd or 3rd quarters each.  No pattern of EAMC was reported in (2%) of the 
affected players. 
A total of 48 (75%) of the players reporting EAMC reported calf muscle cramping. 
This was followed by EAMC of the hamstrings (28%), quadriceps (8%) and foot 
muscles (2%).  No players reported muscle cramping in other muscle groups or 




















In general, players reported the severity of EAMC as minor (lasting on average 2.4 ± 
1.6 minutes).  The majority, of the players 84% reported their EAMC as mild (lasting 
less than 5 minutes before being able to continue exercising) while 6% reported that 
their EAMC was moderate (lasting 5-15 minutes before exercise could be resumed).  
Six of the 64 players who reported EAMC did not indicate the severity of their 
muscle cramping.  None of the players reported whole body cramping, having been 
admitted to hospital as result of muscle cramping or dark urine in the 3 days after a 
cramping episode.  Only 1 player report an episode of EAMC that was associated 
with confusion. 
3.3.10. History of gastrointestinal symptoms  
The prevalence (%) of GIT symptoms during participation in football activities was 
7.2% (10 players).  Of the 10 players reporting gastrointestinal symptoms some 
reported having experienced more than one symptom.  The nature of GIT symptoms 
(expressed as % of players with reported GIT symptoms) were diarrhoea (50%), 
abdominal pain (40%), the urge to defecate (30%), heartburn (20%), nausea (10%) 
and vomiting (10%).  No player reported a history of blood in the stools and none of 
the players reported a history of having had a gastroscopy, GIT ulcers, suffering 
from irritable bowel syndrome, being allergic to milk products or having a past 
history of other GIT disease.  
The retrospective annual incidence (% players who suffered from GIT symptoms in 




21 episodes of GIT symptoms in the preceding year while participating in football 
activities.  Twenty eight episodes of GIT symptoms were reported in the last 10 
matches played by the affected players (an average of 2.8 episodes of GIT 
symptoms per player per 10 matches). 
 
The majority of the players (50%) reported the episodes of GIT symptoms that they 
experienced as minor, having no affect on training or matches and that they could 
continue with activity.  The episodes of GIT symptoms affected (20%) of the players 
performance with these players reporting that they needed to slow down.  The 
episodes of GIT symptoms prevented (30%) of the affected players from training or 
playing football. 
 
3.3.11. Central nervous system symptoms history 
 
The retrospective annual incidence (% players who suffered from CNS symptoms in 
the previous year) of CNS symptoms was 4.3% (6 players) these players reported 
16 episodes of CNS symptoms in the preceding year while participating in football 
activities.  Fifteen episodes of CNS symptoms were reported in the last 10 matches 
played by the affected players (an average of 3.0 episodes of CNS symptoms per 
player per 10 matches).  All of the players (100%) reported the episodes of CNS 
symptoms as minor with no affect on training or matches.  Anxiety was the most 
common symptom reported (2 players) followed by headache, depression and a 
loss of sensation in the feet reported by 1 player each.  One player did not report the 
nature of the CNS symptoms which were experienced.  No players reported any 
symptoms of tingling in the feet or hands or a loss of sensation in the hands. 
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3.3.12. Dermatological history 
The prevalence of previous or current skin conditions was 11.6% (16/138 players). 
The most common dermatological symptoms reported in the affected players were 
skin allergy (44%) and sun burn (44%), followed by skin infection (23%) and other 
skin damage (23%).  No players reported a current or previous diagnosis of skin 
cancer. 
3.3.14. Surgical history 
The prevalence of previous surgery was 49% (68/138 players) in the players.  These 
players reported surgical procedures in 96 anatomical areas as some players 
reported surgery in more than one anatomical area.  In 59 players (87%) the surgery 
was of an orthopaedic nature and in 9 players (13%) it was of a general (non-
traumatic) nature.  The most common orthopaedic surgical procedures (expressed 
as a % of all players) were knee (23.9%) followed by ankle (5.8%), lower leg (5.1%), 
foot (4.3%), shoulder (2.9%), facial (2.9%), nasal (2.9%), wrist (2.2%), finger (2.2%), 
hernia/groin (2.2%), dental (2.2%), head (1.4%), forearm (1.4%), hip (1.4%), lower 
back (0.7%), Achilles (0.7%) and hand (0.7%).  The reported general surgical 
procedures (expressed as a % of all players) were abdominal (1.4%), rectal (1.4%), 
tonsillectomy (1.4%), small bowel (0.7%), testis (0.7%) and ear (0.7%).  No players 
reported a previous surgical history of gastric, oesophageal, colon, gall bladder, 







The main finding of this cross-sectional study was that in the players participating in 
the 2009 Confederation Cup football tournament, exercise associated muscle 
cramping (EAMC) was the most prevalent self-reported medical condition reported 
in elite football players (46% of players).  The prevalence of other common medical 
conditions in this group of football players were allergies (20%), dermatological 
conditions (12%), gastro-intestinal conditions (7%), symptoms of URTI one week 
before the tournament (5%), asthma (4%) and central nervous system conditions 
(4%).  Additional findings were that (52%) of players reported the use of 
supplements or vitamins and (8%) the use of medication.  Finally, 49% of the 
players reported a history of previous surgery with knee surgery being the most 
common anatomical area (24% of the players reporting previous knee surgery). 
 
This study is the first reporting the prevalence of medical conditions in elite football 
players.  Therefore, there are no data in elite football players that could be used for 
comparison to these findings.  These results can however be compared to reported 
data in other athletes, mainly endurance athletes. 
 
Our observed high lifetime prevalence of EAMC in football players (46%) is similar 
to that which has been reported in marathon runners and triathletes (30-50% and 
67% respectively)124,125.  Studies reporting on EAMC in marathon runners have 
associated EAMC with high intensity activity, increased duration of activity and 
subjective muscle fatigue124.  In triathletes, a past history of EAMC and high intensity 
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of activity were associated with EAMC.  Serum electrolyte changes and dehydration 
were not associated with EAMC and other mechanisms such as neuromuscular 
fatigue have been proposed as a cause of EAMC126.  The nature of football cannot 
be compared to marathon running or triathlon directly.  However, football is an 
endurance activity that is performed with numerous short explosive bursts of 
running.  Muscle fatigue due to high intensity running is common in football. 
Therefore, our findings of a similar prevalence of EAMC to marathon running and 
triathlon are consistent with the current model of muscle fatigue as possible cause of 
EAMC.  Furthermore, the high prevalence (76%) of football players reporting the 
onset of muscle cramping in the fourth quarter of training or matches is also 
consistent with the current fatigue model of EAMC.  The calf muscle was the most 
commonly affect muscle (75%) by EAMC in our study and (80%) in marathon 
runners124.  The preferred treatment of EAMC reported by the football players in this 
study was by stretching the affected muscle.  These findings are consistent with 
current literature and hypotheses related to the pathophysiology of EAMC in 
athletes123,127.  The precise incidence of EAMC in footballers has not been well 
documented and thus further studies are needed in this area. 
A personal history of allergy at some time was reported by (19.6%) of the players.  
This prevalence of allergies in football players is lower than that reported in elite 
athletes where the prevalence of allergy has been reported as high as 48%128,129.    
The prevalence of dermatological symptoms in the footballers was 11.6%.  It is well 
recognised that dermatological conditions are common among athletes and that 
such conditions may result in time-loss due to the infective nature of such 
conditions130.  It has previously been reported that dermatological problems are 
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amongst the most common medical problems managed by team physicians, tending 
to athletes while participating in sporting events.  As dermatological conditions were 
not the main focus of this study and as skin conditions in athletes have been 
reviewed comprehensively elsewhere54,130, dermatological conditions will not be 
discussed further.  However, the results from our study do indicate that team 
physicians to football players require a good working knowledge of dermatology.  
The prevalence of gastro-intestinal symptoms reported in the elite footballers of 7% 
(0.3 episodes of symptoms per match in affected players) is lower than that of 
previous studies, where the lifetime prevalence of GIT symptoms associated with 
running range from 20-83%65.  Diarrhoea was the most frequently reported GIT 
symptom followed by abdominal pain. Upper gastrointestinal symptoms such as 
heartburn, epigastric pain, nausea, and vomiting are reported by 20-50% of 
endurance athletes67 and up to 50% of athletes during high-intensity exercise68.  As 
there are no other studies describing football players, further research is needed to 
investigate this difference.    
The reported familial history of asthma and allergies of 14% is similar to that which 
is reported in the general population45 but lower than other studies reporting on elite 
athletes, it has been reported that 42% of Australian Olympic athletes had a positive 
family history of allergy48.  The reported familial history of asthma in 10% of the 
football players is also as would be expected in the general population, but lower 
than that reported in other studies involving athletes.  Previous studies investigating 
asthma in elite athletes, report the prevalence of a positive family history of asthma 
to vary from 11% to 19%128.  The reported prevalence of asthma was 4.3% and this 




other sporting activities.  Data obtained from the 1984 United States Olympic team 
found that 67 (11%) of 597 athletes had a history of asthma or experienced EIA131 
and a previous study investigating asthma in elite athletes reported a prevalence of 
14% of the athletes investigated48.  Furthermore, 23% of Australian Olympic athletes 
reported that they experience asthma48.  The low prevalence of asthma in elite 
footballers is not known.  It is also interesting to note that the most common current 
allergic condition reported in (7.2%) of the players, was that of a plant allergy.  
These findings require further research.  
 
The prevalence of central nervous system symptoms was (4%) with anxiety being 
the most common symptom reported.  There are not data in other groups of athletes 
where the prevalence of CNS symptoms was measured and these data could 
therefore not be compared with other sports. 
 
Medication use in athletes has been well documented132.  In this study, only 11 (8%) 
of the players reported the use of medication.  Compared to previous reports of 
medication use in Olympic athletes, this prevalence is low and reflects either an 
under reporting of medication used or a particularly healthy group of players.  61% 
and 54% of Canadian athletes reported the use of medication during the Atlanta and 
Sydney Olympic Games respectively133.  The low use of medication in footballers in 
this study when compared to the 1996 and 2000 Canadian Olympic athletes may be 
due to a positive response of the players to the large educational campaign to 
discourage the use of medications and supplements in elite sport, given the 
potential risk of contamination with prohibited substances.  Furthermore, the 1996 
and 2000 data reflect medication use in elite Canadian athletes, and thus may 




culturally never been large medication users.  As in previous studies, asthma, 
allergy and anti-inflammatory medication were the most commonly used type of 
treatment.  Medication use during international football tournaments has previously 
been reported as an average intake of 0.63 substances per player per match, with 
the use of non-steroidal anti-inflammatory medications being the most commonly 
used medication134.  Data from 6 FIFA tournaments for female and youth players 
found that 37.9% of all players reported the consumption of at least one form of 
medication within 72 hours before matches134.  Non-steroidal anti-inflammatory 
drugs were the most frequently prescribed group of substances and 17.3% of under-
17 players, 21.4% of under-20 players and 30.7% of female players reported the 
use of NSAID’s134.  Furthermore, the use of NSAID’s during the 2002 and 2006 FIFA 
World Cup tournaments was reported as 54% of all the players taking NSAID’s 
during the tournament and 10% of the players taking an NSAID before every 
match135.  B2-agonists were prescribed to 2.1% of all players and general asthma 
medication to 3.5% of the players134.  859 of 6577 (13.1%) of prescription 
medication was for respiratory tract conditions.  The recommendations for the 
diagnosis and management of asthma in elite athletes are continually being 
reviewed due to the potential abuse of asthmatic medication41. 
 
The use of nutritional supplements by the elite football players participating in this 
study are comparable with data reported elsewhere.  This study found that 72 (52%) 
of the 138 players reported the use of either supplements or vitamins and 59 (43%) 
of the players reported the use of vitamins only.  A meta-analysis of 51 studies, 
reporting non-anabolic nutritional supplement use in athletes, found an over overall 
prevalence of supplement use of 46% in 10 247 athletes at all levels, participating in 
15 sports136.  Of the Canadian athletes participating in the Atlanta and Sydney 




dietary supplement133.  This also correlates with the reported supplement use of 
48.8% and vitamin use of 43.2% as observed in athletes participating in the Athens 
2004 Olympic Games137.   
 
A history of previous orthopaedic surgery was reported by 43% of the players.  The 
data collected reflects previous surgery and not previous injuries.  The data only 
reflects the number of surgical procedures performed on specific anatomical areas 
as players were not requested to specify how many times any specific body area 
was operated on previously i.e. the players were not required to report if an area 
was operated on more than once.  It remains of interest to document previous and 
current injuries, especially injuries just prior to a tournament as injuries are an 
important cause of time-loss in athletes.  The result from this study (43% prevalence 
of a history of previous surgery) is consistent with the data from a study assessing 
the orthopaedic component of a standardized pre-competition medical assessment.  
Of 553 players participating in the 2006 FIFA World Cup, 223 (41.1%) reported at 
least 1 surgical procedure due to a sports injury and 278 (51%) reported to have 
sustained at least 1 significant injury during their career138.  Previous knee injuries 
were the most commonly reported injury in 121 (22.2%) of the players followed by 
ankle injuries in 95 (17.4%) of the players in the World Cup study.  In both this study 
and the 2006 FIFA study knee surgery was reported in 24% of the payers and ankle 
surgery in 8 (6%) and 40 (7.4%) of the players for this study and the World Cup 
study respectively.  The high frequency of injuries and surgery reported reflect the 






In our study, the players’ body compositions and physical fitness characteristics 
(such as strength, speed, agility and endurance) were not examined.  However, this 
is the first time that hand and leg dominance has been documented in elite football 
players.  As being able to play the ball with both feet is an essential skill for football 
and young football players are coached to kick with both feet, it is not surprising to 
note that 8% of the players reported being able to use both legs but only 1% of the 
players reported using both hands.  As the demographic data of players may also be 
relevant when examining the incidence and nature of injuries this may form part of 
future studies. 
 
Four (3%) of the players reported that they were smokers and 58 (42%) that they 
consumed alcohol, generally at a low weekly consumption.  Even though other 
studies have reported a 0% prevalence of smoking in elite athletes128, it may be 
considered that these results are not a true reflection of the actual prevalence of 
smoking and alcohol consumption in elite football players.  This was likely due to 
under reporting due to fear of possible exposure. 
 
3.4.1. Strengths and limitations of this study 
 
The main strengths of this study are that 1) it is the first study to document the 
prevalence of medical conditions in elite football players’ and, 2) it utilized previously 
validated medical history questionnaires.  In addition, the methodology utilized in 
this study can now be adapted and utilized in future research setting. 




The main limitation to this study is that the individual response rate for this study 
was only 75% and the team response rate was 87.5% (due to 1 team not 
participating in the study).  However, these response rates compare favourably with 
those reported by FIFA during international football tournaments where an average 
response rate of 84% for football studies has been reported (ranging from 47% to 
100%)26.  No specific reason as to the unwillingness of one team to participate was 
given.  As the study documentation and questionnaires were only available in 
English, language difficulty and translation problems may have contributed to non-
compliance.  Only 3 of the teams used English as an official home language.  For 
future studies of this nature, it may be important to address this concern and present 
the questionnaires in more languages.    
 
A further limitation of this study was that all the data were self reported and was 
based on recall over a period of a few weeks. The limitations of self-reported data 
need to be considered when evaluating these results.  The quality of the data 
collected also varied both in team and individual context, some sections were not 
completed accurately or neglected totally.  This problem has previously been 
observed in a study reporting on the implementation of a pre-competition medical 
assessment in elite footballers, where the completion of forms returned varied from 
34% to 94% among the teams139.  This highlights a need for improved research 
methodology and the implementation of a standardized, “user-friendly” reporting 
form is suggested.  Furthermore, no special investigations were performed to 
confirm the presence of medical condition and no official medical reports were 
collected or included in the study to validate any player’s medical condition.  Thus, 





3.4.2. Summary and conclusions 
 
In summary, the present study was the first study that investigated the prevalence of 
general medical conditions in elite footballers.  The assessment of injury and illness 
data allows for future planning of medical care provided to elite athletes. The data 
show that elite footballers are affected by a wide spectrum of medical conditions that 
are related to both athletic activity and general medical conditions.  The prevalence 
of such a wide spectrum of medical conditions highlights the need for appropriate 
medical support for elite football players.  Team physicians taking care of elite 
football players need to be well trained and need to have the necessary skills and 
experience to manage both injuries and a wide spectrum of medical conditions.  
Further studies are required to investigate the relationship between the various 
medical conditions and aspects such as training history, environmental factors and 





The incidence of injuries and illness reported during an elite 
international football tournament 
4.1. Introduction 
The incidence and nature of injuries sustained by elite athletes, while participating in 
sporting events of various sporting codes, have been well documented140,141.  In 
particular, the incidence and pattern of football injuries during previous international 
FIFA tournaments, including the 2006 FIFA World Cup in Germany have been well 
studied25.  The FIFA Medical Assessment and Research Centre (F-MARC) began 
the study of injuries during the final rounds of the 1998 FIFA World Cup in France.  
Injuries in all subsequent competitions organised by FIFA as well as the football 
tournaments during the Olympic Games in Sydney and Athens have been 
monitored25.  In contrast, the incidence and nature of general medical conditions and 
illness prior to, during or after international competitions have, to our knowledge, not 
been studied in elite football players. 
The aim of this study was to determine the incidence and nature of such medical 
conditions and illness in elite football players, and follows on the research that was 






4.2.1. Type of study 
 




The UCT/MRC (University of Cape Town / Medical Research Centre) Research Unit 
for Exercise Science and Sports Medicine, together with F-MARC (FIFA Medical 
Assessment and Research Centre) (Switzerland), conducted this study to determine 
the incidence of medical conditions and illness in the elite football players who 
participated in the 2009 Confederations Cup football tournament.  The research 
protocol was approved by the University of Cape Town Health Sciences Research 
and Ethics Committee (REC REF: 159/2009) (Appendix 2) and the Institutional 
Review Board of F-MARC. 
 
All 184 of the elite male football players participating in the 2009 FIFA 
Confederations Cup football tournament were included as potential subjects for this 
study.  Prior to the start of the tournament, information regarding all the components 
of the planned research study was made available to the eight team physicians that 
were to accompany the players participating in the tournament.  The team 




the research study to each player in their respective teams.   These details as well 
as all the potential risks and benefits of the study were explained to the players 
through a detailed subject information sheet (Appendix 3).  Potential subjects were 
approached by the FIFA Medical Assessment and Research Centre, through their 
team physicians, and invited to participate in the study.  Detailed information and an 
informed consent form (Appendix 4) for completion, was given to each player.   
 
4.2.3. Daily injury and illness log   
 
The team physicians from each of the participating teams were requested to 
complete a daily injury and illness log for the players in their respective teams each 
day during the 15-day competition (Appendix 6).  The necessary documentation 
forms were distributed and collected by the F-MARC medical officers who were 
appointed to each venue during the tournament.  To ensure that consistent and 
comparable data were collected, the injury definitions, research methodology and 
implementation as proposed by the 2006 FIFA Injury Consensus Group and used by 
F-MARC in previous FIFA tournaments was used24. 
 
4.2.3.1. Injury recording 
 
An injury was defined as any physical complaint sustained by a player that resulted 
from either a football match or during football training, irrespective of the need for 
medical attention or time-loss from football activities.  An injury that resulted in a 
player receiving medical attention is referred to as a “medical-attention” injury and 
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an injury that resulted in a player being unable take a full part in future football 
training or match play as a “time-loss” injury. Furthermore, injuries were classified, 
whether they occurred during match or training sessions and also whether they were 
the result of contact with another player or other object.  Any potential injuries that 
were unrelated to football competition or training were not recorded as football 
injuries. 
Match exposure was defined as play between teams from different countries and 
training exposure was defined as team-based and individual physical activities 
under the control or guidance of the team’s coaching or fitness staff that were aimed 
at maintaining or improving players’ football skills or physical conditioning.  Pre-
match warm-up and post match cool-down sessions were recorded as training 
exposure.  The time during a match at which an injury occurred was recorded. 
Injuries were also classified according to location (body site), type, mechanism of 
injury (traumatic or over-use) and diagnosis.  Recurrent injuries were also recorded 
and the severity of an injury and illness was reported as the expected absence in 
days from football activities24,25.  In each case the injury was diagnosed by the team 
physician, who is an experienced and qualified medical practitioner. 
The comprehensive injury report data collection form as used in similar surveys at 
international football competitions and at the Olympic Games was used and 
modified to include illness data.  The injury and illness report form was comprised of 
one page to complete.  The form was largely in a tick-only format and data was 
coded as far as possible so as to improve the quality of data collected.  The location 




The incidence of injury was expressed as 1) number of injuries per match, 2) 
number of injuries per 1000 match hours and 3) number of injuries per 100 player 
days.  The total number of match hours played was calculated as follows, (22 
players x 90 minutes x 16 matches) / 60 minutes = 528 match hours.  Extra time and 
a reduced numbers of players on the field due to injury or being sent off (red carded) 
were not taken into account as only a few matches went into extra time and the 
exclusion of players was a rare exception.  This same methodology has been used 
by FIFA in previous studies reporting on football injuries.  Using the same 
methodology ensures that the results can be compared directly to previous FIFA 
studies. 
 
4.2.3.2. Illness recording 
 
Medical conditions and illnesses were defined as any non-trauma related symptoms 
or signs presenting in a player that needed medical attention from the team 
physician.  All the non-traumatic complaints such as illness and psychological 
complaints were recorded in a separate section of the daily injury and illness log 
form (Appendix 6). 
 
Illness data collected included the affected system, a final diagnosis, symptoms and 
signs, cause of illness, treatment and absence from play (in days).  The information 
that was included was the same as that which the team physician would have 
obtained during normal clinical care of the players in his team.  The clinical 
information was reported by use of a sport-specific injury coding system, as 
previously described142. 
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Illness data has, to our knowledge, not been recorded in previous studies. 
Therefore, a method of illness recording was first developed based on a system 
codes.  This coding system was based on the International Classification of 
Diseases (ICD) 10 coding system.  Furthermore, the incidence of illness was not 
expressed according to playing hours as injuries are, but rather as illness per team 
days and illness per 100 player days.  In each case, the injury was diagnosed by the 
team physician, who is an experienced and qualified medical practitioner. 
The number of team days was calculated as follows: 
8 teams participated for the first 7 days of the tournament, this constitutes 56 (8 
teams x 7 days) team days.  6 teams participated on the 8th day, this constitutes 6 (6 
teams x 1 day) team days.  This was followed by 7 days during which the semi-finals 
and quarter finals were played.  Only 4 teams participated during this period, this 
constitutes 28 (4 teams x 7 days) team days, therefore a total of 90 team days for 
the duration of the tournament. 
The number of player days was calculated as follows: 
The duration of the tournament was 15 days.  All of the 8 teams of 23 players each 
participated in the first round knockout stage of the tournament, for the first 7 days, 
this amounted to 1288 (8 teams x 23 players x 7 days) player days.  On day 8, 6 
teams remained in the tournament as 2 teams were knocked out on the previous 
day, this amounts to 138 (6 teams x 23 players x 1 day) player days.  This was 
followed by the remaining 7 days which consisted of the semi-finals and final 




players x 7 days) player days.  The total number of player days for the tournament 
was thus 2070 [(184 x 7) + 138 + (92 x 7)] player days.  The tournament fixtures and 
related player days for the duration of the tournament are listed in Appendix 7. 
 
4.2.4. Environmental conditions during the tournament 
 
Daily data on the weather conditions at each venue for the duration of the 2009 
Confederations Cup were obtained directly from the South African Weather Service 
(www.saweather.co.za). 
 
4.2.5. Statistical analysis of the data 
 
All the data from the questionnaires was entered on to Excel spreadsheets 
(Microsoft Office 2007).  The data was analysed using standard statistical methods.  
All numerical data is represented by the mean ± standard deviation (SD), with the 
number of subjects in parenthesis.  Categorical data are expressed as percentages 








4.3.1. Response rate 
Of the possible 90 injury and illness incident report forms for the 8 teams, 63 (70%) 
were returned.  Twenty seven (30%) of the possible 90 reports were not collected.  It 
is not known whether the reports were not returned due to non-compliance or if 
there were no injuries or illnesses to report on these days.  There were 16 (17.7%) 
team days where no injuries or illnesses were reported.   
4.3.2. Injuries and illnesses 
4.3.2.1. Injuries 
During the tournament 56 injuries were reported.  Of the 56 injuries reported, 22 
(39%) were reported during training and 34 (61%) injuries reported during the 16 
matches played.  This corresponds to an overall injury rate of 64.4 injuries per 1000 
match hours or 2.1 injuries per match.  Twenty three (68%) of the 34 reported match 
injuries occurred in the second half of play, 10 (29%) occurred in the first half of play 
and the time of injury was not reported for 1 injury.  The average elapsed time 
during matches at which point injuries occurred was at the 60th minute of match 
play.  
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The frequency of the reported location of injuries (injured body parts), are depicted 
in figure 4.1.  The thigh was the most commonly injured body part (19.6% of all 
injuries), followed by the knee, ankle, foot and lower leg injuries.  The majority of 
injuries occurred in the lower limbs. 
Figure 4.1.:  The frequency of the location of injuries sustained by the players 
participating in the 2009 Confederations Cup (expressed as % of all injuries)   
The frequency of the types of injuries reported during the tournament, are depicted 
in figure 4.2.  The most common type of acute injury was a contusion (39.3% of the 
injuries reported) followed by ligament sprains (17.8%), muscle strains (10.7%) and 

































Percentage of all injuries
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Figure 4.2.: Frequency of the type of injuries sustained in the players 
participating in the 2009 Confederations Cup (expressed as % of all injuries) 
The frequency of the mechanisms or causes of the injuries sustained during the 
2009 Confederations Cup are depicted in figure 4.3.  Player contact was reported to 
be the cause of injury in the majority (55.4%) of the injuries, followed by overuse 
































Figure 4.3.:  The frequency of the mechanisms of the injuries reported in the 




For the 56 injuries reported, there were 49 days of time lost due to the injuries.  An 
average of 0.88 days was therefore lost per injury for the tournament.  In 37 (66%) 
of the injuries, no time was lost and the players could resume normal football 
activities directly after the injury.  1 day of time was lost in 7 of the injuries, 2 days in 
6 of the injuries, 3 days in 3 of the injuries and 7 days in another 3 injuries.  During 
these days, the injured players were not able to train or play matches.  1 player 
reporting a 7 day time loss injury had to withdraw from the tournament due to his 





















Percentage of all injuries
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4.3.2.2. Illness 
During the 2009 Confederations Cup tournament, 35 illnesses were reported.  The 
frequency of the systems that were affected by illness during the 2009 
Confederations Cup is depicted in figure 4.4.  The majority (57.1%) of the reported 
illnesses affected the respiratory system, 13 (37%) due to ENT conditions and 7 
(20%) due to respiratory tract symptoms.  This was followed by the dermatological 
system (17.1%) and the digestive system (14.3%).   
Figure 4.4.: The frequency of systems affected in the players participating in 














Percentage of all illnesses
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The frequency of main symptoms / signs reported, are depicted in figure 4.5.  The 
most common main symptom or sign reported in the 35 illnesses was pain (31%) 
followed by a cough in (22.9%). 
Figure 4.5.: Frequency of symptoms and signs affecting the players 
participating in the 2009 Confederations Cup (expressed as % of all illnesses) 
The frequency of final diagnoses for the reported illnesses in the players, are 
depicted in figure 4.6.  Sinusitis was the most common diagnosis made by the team 
physicians (31% of the illnesses that were diagnosed in the players) followed by 





























Figure 4.6.: The frequency of final diagnoses (made by the team physicians) 
due to illness in the players participating in the 2009 Confederations Cup 
(expressed as % of all illnesses) 
 
 
The frequency of causes for the illnesses in the study, are depicted in figure 4.7.  Of 
the illnesses reported by the team physicians, (42%) were reported to be due to 





























Percentage of final diagnoses 
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Figure 4.7.: The frequency of the causes of the illnesses in the players 
participating in the 2009 Confederations Cup (expressed as % of all illnesses)  
The 35 illnesses reported resulted in 16 days of time lost to the players due to 
players being unable to train or play due to their illness.  An average of 0.46 days, 
were therefore lost per illness for the tournament.  In 26 (74%) of the illnesses no 
time was lost and the players could continue normal football activities after medical 
management.  1 and 2 days of time were lost in 4 (11%) of the illnesses each and 4 
days in 1 (3%) player.  During these days, the injured players were not able to train 














4.3.2.3. Comparison of injury and illness 
The incidence of injury and illness per 100 player days and the time lost as result of 
injury and illness is depicted in figure 4.8 and 4.9., respectively.  The time lost due to 
illness was half of that due to injury. 
Figure 4.8.: The incidence of injuries and illnesses (per 100 player days) in the 


















Figure 4.9.: The number of days lost per injury or illness reported in the 
players participating in the 2009 Confederations Cup 
 
 
The number of daily reported injuries and illnesses per 100 player days, corrected 
for the number of players remaining in the tournament once teams had been 
eliminated, are depicted in figure 4.10.  The greatest number of injuries reported per 
100 player days was 4.89 injuries / 100 player days and these were reported on the 
first day of the tournament. The greatest number of illnesses reported per 100 player 
days was 4.35 illnesses / 100 player days and these were reported on the last day 
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Figure 4.10.: The daily incidence of injuries and illnesses during the 2009 
Confederations Cup tournament (incidence per 100 player days) 
4.3.3. Environmental factors 
During the competition, data regarding the environmental conditions at each of the 
host city venues, at team base camps and at competition venues were obtained 
from the South African Weather Service.  The average minimum and maximum 
temperatures, humidity and wind speeds were recorded during the tournament and 












































4.4. Discussion   
 
The aim of this study was to describe the incidence and nature of medical conditions 
and illness experienced by the elite professional football players participating in the 
2009 Confederations Cup tournament. 
 
The main findings of this study were that during the 2009 Confederations Cup 
Football tournament, 1) the overall rate of injuries was 64.4 injuries per 1000 match 
hours or 2.1 injuries per match, 2) 2.7 injuries and 1.7 illnesses were reported 
respectively per 100 player days, 3) 0.88 days were lost per injury and 0.46 days 
were lost per illness, 4) lower limb injuries were the most common injury, 5) 




The overall injury rate of 64.4 injuries per 1000 match hours or 2.1 injuries per 
match is very consistent with that previously reported for the Confederations Cup 
1999 (1.7 injuries per match) and the Confederations Cup 2001 (2.1 injuries per 
match)26.  This injury rate is also slightly lower when it is compared with the 2.3 
injuries per match were reported in the 2006 FIFA World Cup and 2.7 injuries per 
match that were reported in the 2002 FIFA World Cup26.  The incidence and 
characteristics of the injury data that we report in this study is therefore comparable 
with the data collected at previous FIFA World Cup and Confederation Cup 
tournaments and has been summarized in table 4.1.  
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Table 4.1.: Incidence and characteristics of injuries recorded in 4 international 












Cup South Africa 
No. of matches 64 64 16 16 
Player match 
hours 
2112 2112 528 528 
No. of match 
injuries 
171 145 33 34 
Injuries per 1000 
match hours 
80.96 68.7 62.5 64.4 
Injuries per match 2.7 2.3 2.06 2.1 
Circumstances, %, (n/total number) 
Non-contact 27%, (45/167) 27%, (38/143) 9%,  (3/33) 3%, (1/34) 
Contact 73%,(122/167) 73%, 
(104/143) 
91%, (30/33) 56%, (19/34) 
Time, % (n) 
First half 54%,  (88) 50%, (66) 45% (15) 29% (10) 
Second half 46%, (72+3) 50%, (64+2) 55% (18) 68% (23) 
Estimated severity, % (n) 
0 Days 33%, (53) 30%, (39) 61% (20) 70% (24) 
1-3 days 37%, (59) 33%, (43) 18% (6) 21% (7) 
>3 days 40%, (48) 37%, (49) 21% (7) 9% (3) 
Time loss injuries 107 92 13 10 
Injuries per 1000 
hours 
50.7 43.6 24.6 18.9 








As reported in other studies, and documented in the present study, player contact 
was the most common cause of injury.  It has previously been reported that 55% of 
injuries occur in the second half of the match.  In our, study 68% of the injuries 
occurred in the 2nd half and this finding is therefore consistent with that previously 
reported. 
 
In the present study, the days lost per injury were 1 day for every injury sustained 
during match play and 0.68 days lost for every injury sustained during training.  This 
translates to an overall rate of 0.88 days lost per injury.  These data cannot be 
compared to previous studies as days lost have not been reported in this way in 
previous studies.  New injuries were reported on a daily basis and injuries already 
recorded were not followed up or progressively recorded for this study.  The 
reported duration of time lost was thus an estimate based on the clinical diagnosis 
and experience of the team physician managing the player. 
 
As reported in previous studies, the most common injuries were to the thigh and 
knee.  Lower limb injuries in general were common.  Contusions were the most 
common type of injury followed by sprains.  The frequency, location, nature and 
severity of the injuries reported during match play in this present study were 
therefore similar to those described in previous literature (table 4.2.)25.26. However, 
the match play incidences of knee, ankle and head injuries were less common than 
those reported in previous tournaments25,26.  Recent “rule” changes have prevented 
players from lifting their elbows when jumping for a high ball to possibly reduce the 
number of head injuries sustained during matches.  This could have resulted in a 
reduction in the number of concussion injuries seen in the present study.  
Furthermore, the implementation of this “rule” may also be the reason for the 
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reduction in head injuries that we observed in our study.  The lower incidence of 
knee and ankle injuries, when compared to previous studies, could not be explained 
from the data collected.  Further studies are recommended to determine if this 
observation is consistent.  It is possible that a reduction in injuries can be accounted 
to an improvement in medical care and physical conditioning of footballers over the 
last decade.  In particular, F-MARC has recently launched its F11+ injury prevention 
program and the implementation of this programme in teams could perhaps have 
reduced the incidence of injuries in the present study.  
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Table 4.2.: Frequency of injury by location and type reported during match 
play in 4 international football tournaments   
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The importance of non-traumatic medical conditions in elite footballers has been 
highlighted in this study.  In this study, 56 injuries and 35 illnesses were reported, 
translating to an incidence of 2.7 injuries and 1.7 illnesses per 100 player days.  
Although the incidence of illness is less than the incidence of injury reporting, the 
results of this study show that illness constitutes a significant part of the medical 
management of elite football players.  The number of days lost per illness is also 
half that of the number of days lost per injury, with an average of 0.46 days lost per 
illness.  For every injury reported there are 0.6 illnesses reported and for every day 
lost due to injury there are 0.3 days lost due to illness.  Illness therefore adds a 
significant burden of disease to a team and further research to help guide medical 
planning for events such as these is recommended.   
In studies reporting the incidence of injuries and illness during other elite sporting 
events such as the Olympic Games, as many as 69% of the medical contacts are 
reported to be due to non-traumatic medical conditions (illness)70.  The only study 
investigating the incidence of illness in football reported that 32.7% of the medical 
consultations were for illnesses81.  In the present study, illness accounted for 38% of 
all the medical consultations.  This is lower than that which has been published in 
other elite sporting events but is comparable to the only football specific study.  In a 
retrospective study that investigated the incidence of injuries and illness of one team 
participating in two international football competitions, 102 (73%) of the football 
player consultations were for injuries and 38 (27%) were for illnesses81.  The lower 
incidence of medical conditions in the football studies may be due to a relatively 
higher incidence of injuries in football, a contact sport when compared to multi-
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disciplinary events such as the Olympic Games.  Previous studies do not report their 
incidence data as (n) / 100 player days and therefore it is not possible to directly 
compare the incidence of illness from our study to that in other studies.  Further 
studies with better methodology are needed to examine the possible differences.    
The frequency of injury and illness has been reported for both athletes and officials 
in the three studies at the Olympic Games70,71,104.  It is important to note that these 
studies report the number consultations and not the true incidence of cases.  In 
addition, no mention is made of follow-up consultations.  It is therefore not possible 
to compare the results of our study directly to the results from previous studies.  In 
our study, incidence of illness was determined as each case was only recorded 
once (as a new illness).  Follow-up medical consultations were not reported.  The 
true burden of disease is underestimated and the burden on the team physician is 
higher as players with injury or illness will be re-assessed and managed daily. 
In our study the injuries and illnesses were reported by team physicians, who were 
familiar with the players, their medical histories and the questionnaire used. 
Furthermore a previously validated questionnaire and coding system was adapted 
and then used.  The injury report form comprised a single page on which all injuries 
(or where applicable the non-occurrence of injuries) during a given match was 
recorded.  This method of documentation helped to distinguish the absence of injury 
or illness from missing data. The consistent findings outlined in this study, when 
compared to previous studies, is an indication of the reliability of the methodology 
used and the quality of the data collected. 
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Travel related medical conditions include allergies, minor infections, waterborne 
diseases, tropical diseases and HIV.  The occurrence of tropical diseases such as 
malaria, tick-bite fever and bilharzias have previously been reported in athletes but 
not in elite professional footballers.  A previous review of the travel related medical 
concerns, providing a framework on which medical planning can be based has been 
published for the Sydney Olympic Games100.  Areas which need to be covered 
include immunisations, personal health, sexual health, dental assessments, jet lag, 
malaria prevention, culture shock and environmental factors. 
Tropical infections have been reported in athletes participating in events in regions 
with a risk for developing such illnesses.  None of the 2009 Confederations Cup 
matches were played in malaria endemic areas, but the teams may have combined 
their official match schedule with vacation periods on game farms or guest lodges in 
the bush.  In such environments, the players could have been exposed to tropical 
diseases such as malaria, bilharzias and African tick bite fever.  Fortunately, there 
were no tropical diseases reported by the subjects in this study.  As the study period 
was in the winter month of June such tropical diseases are not generally prevalent. 
As highlighted previously in this discussion, various environmental factors can 
impact on the frequency and nature of the medical conditions experienced by the 
participants of sporting competitions.  Environmental considerations for athletic 
performance at the Beijing Olympic Games were reviewed previously and the 
importance of temperature, ultraviolet radiation, allergens atmospheric pollution and 
altitude on athletic performance and illness was highlighted143.  Pollen and airborne 
allergen counts in midwinter in South Africa are low, other than the possibility of 
fungal spores in the Natal coastal region144.  Players from warmer environments 
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may need a few days to acclimatize to the colder conditions but in general the winter 
weather is mild when compared to a European winter with temperatures rarely 
dropping below zero degrees centigrade.  
Over the 15 day tournament, the incidence of injuries per 100 player days appears 
to have declined with 4.89 injuries per 100 player days reported on day 1 and no 
injuries reported on the last day of the tournament, day 14 (figure 4.10.).  In contrast, 
it is interesting to note that the incidence of illness per 100 player days seemed to 
increase towards the end of the tournament, with 2.17 and 4.35 illnesses per 100 
player days reported on day 1 and 14 respectively.  As the study population was 
small, it was not possible to determine a statistical significance of this observation. 
It will be interesting to follow this study up with a bigger tournament with more 
players and a longer duration to determine the validity of this observation.  It is 
presumed that the longer the tournament the greater the exposure to disease and 
the more fatigued and emotionally stressed the players will become, increasing their 
chance of becoming ill. 
4.4.3. Strengths and limitations of this study 
The main strengths of this study are that 1) it is the first study to document the 
incidence of illness during a football tournament, 2) it utilized a prospective cohort 
design, and 3) it utilized previously validated injury recording procedures.  In 
addition, the methodology utilized in recording illness during this study can now be 




The main limitation of this study is that the response rate for this study was only 
70%.  However, this response rate is compatible with the response rates in similar 
previous studies conducted by FIFA, where an average response rate of 84% for 
football studies has been reported (ranging from 47% for the Confederations Cup 
1999 to 100% in the Confederations Cup 2001)26.  The data collected can therefore 
be considered a good representation of the cohort group being studied.  However, 
for future studies of a similar nature, an attempt must be made to ensure that the 
response rate is optimal.  This can be achieved by better communication between 
the researcher and the team physicians and turn their communication with the 
players.  Emphasis on the expected gain in knowledge and confidentiality of the 
collected data will help motivate participation.  The importance of the study 
methodology and questionnaire relevance need to be addressed in future studies. 
 
A further limitation of this study was that the sample size was relatively small and 
the duration of the tournament was relatively short (15 days).  Therefore, a detailed 
analysis of some parameters such as patterns of illness and injury over the time 
period could not be conducted. 
 
Finally, air pollution (sulphur dioxide, sulphides, oxides of nitrogen, particulate 
matter and Ozone) and pollen count data could not routinely be recorded in the host 
cities of this tournament.  Therefore, any correlations between air pollution or aero-
allergens and atopic or respiratory illnesses could not be made.  Environmental data 
has previously been available prior to an elite sporting event, during the 2004 
Athens Olympics, an aerobiological surveillance network was set up to provide 
athletes with information on the current pollen counts.  Fortunately, air pollution and 
aero-allergen levels in South Africa do not appear to have a significant impact on 
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sporting events.  However, due to the general occurrence of atopic disease, it would 
seem that the organizing officials of elite athletic events need to ensure that such 
facilities are in place for all major events such as the World Cup football tournament 
and team physicians must be provided with the relevant environmental data before 
the event. 
4.5. Summary and conclusion  
In summary, the present study provides new evidence that non-trauma related 
medical conditions contribute significantly to an international football tournament’s 
need for medical care.  Furthermore, the assessment of injury and illness data 
allows for future medical care planning provided to elite footballers. The data show 
that elite footballers are affected by a wide spectrum of medical conditions that are 
both related to athletic activity and to general medical conditions.  The incidence of 
such a wide spectrum of medical conditions highlights the need for appropriate 
medical support for elite football players.  The team physicians taking care of elite 
football players need to be well trained and have the necessary skills and 
experience to manage both injuries and a wide spectrum of medical conditions. 
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Chapter 5 
Summary and conclusion 
The purpose of this dissertation was to investigate medical conditions and illness in 
elite football players.  Ultimately, the aim was to provide data and recommendations 
for future studies investigating medical conditions and illness in elite athletes in 
general and footballers in particular. 
The first main novel contribution of this dissertation was a documentation of the 
most common pre-tournament medical conditions in the players participating in the 




Table 5.1.:  The prevalence of general medical conditions reported in 
the players participating in the 2009 Confederations Cup Football 
tournament (expressed as number of players and % of all the players) 
Condition Number of players Percentage 
Exercise Associated Muscle Cramps (EAMC) 64 46% 
Allergy 27 20% 
Atopic family history 20 14% 
Dermatological conditions 16 12% 
Upper Respiratory Tract (URT) symptoms 12 8.7% 
Gastrointestinal conditions 10 7% 
Asthma 6 4% 
Central nervous system conditions 6 4% 
 
 
Pre-existing medical conditions may affect an athlete’s performance and 
undiagnosed medical conditions may expose an athlete to a risk of medical 
complications.  Therefore, the documentation of medical conditions in athletes will 
assist team physicians in the identification of risk patterns and help guide pre-
participation medical examinations to improve medical care delivered to athletes.  
Only limited data are available on the prevalence of common medical conditions that 
may affect elite athletes and it appears that there are no data on the prevalence of 
medical conditions in elite footballers.  From the data describing the prevalence of 
medical conditions and illness in athletes, it can be concluded that medical 
conditions are common in athletes and the prevalence of reported conditions 
depends on the condition reported and the population described.  To date, the most 




gastrointestinal complaints, skin infections and allergic conditions.  The most 
prevalent condition reported in this study is EAMC. This is the first study to report 
the lifetime prevalence of EAMC in footballers.  This finding requires further 
investigation. 
 
The second novel contribution from this dissertation is the documentation of the 
incidence of medical conditions and illness in elite football players participating in an 
international tournament.  A literature review revealed that there are limited data on 
the incidence of illness during international sports competitions.  From the limited 
research, it has been shown that the incidence of medical conditions and illness 
varies but that 27-69% of consultations in athletes are due to medical (non-trauma 
related) conditions.  Where this has been documented, the incidence of illness is as 
common as the incidence of injury.  Furthermore, the most common medical 
conditions reported in athletes are upper respiratory tract infections, gastrointestinal 
complaints and skin infections.  The focus of this dissertation was on football players 
and the reason for this was that to date, there is only one study describing medical 
conditions and illness in elite footballers.  These data are important because 1) 
many of these medical conditions may affect an athlete’s performance and 2) this 
information can assist team physicians and event organisers with optimal planning 
of medical care to athletes in general and footballers in particular. 
 
The data presented in this dissertation have contributed to the current body of 
scientific literature on the incidence of medical conditions in elite football players 
participating in an international tournament.  The data represented in this 






Table 5.2.:  The frequency (n = number of consultations) and 
percentage (%) of all formal medical consultations in elite athletes 
participating in tournaments / competitions [2000 and 2004 Olympic 
Games (South African and New Zealand teams), the 2003 Cricket World 
Cup (All teams), the 2006 FIFA World Cup and 2007 CONCACAF Gold 

















































Injuries (345) 53% (108) 31% (72) 40% (48) 53% (117) 67% (102) 73% (56) 62% 
Illnesses (308) 47% (240) 69% (108) 60% (42) 47% (57) 33% (38) 27% (35) 38% 
Ear nose & throat 3% 18% 13% 0 4.5% 4% 14% 
Respiratory 18% 16% 8% 14.5% 9% 9% 8% 
Neurological 1% 16% 4% 3% 2% 2% 2% 
Gastrointestinal 4% 6% 6% 7% 7% 2% 5.5% 
Dermatological 7% 2.5% 16% 8% 3.5% 3% 6.5% 
Urological 0.5% 2.5% 0.5% 3% 0 0 1% 
Psychological 0 2% 3% 0 3.5% 3.5% 0 
Cardiology 0.5% 1% 3% 0 0 0 0 
Ophthalmology 2% 0.5% 0.5% 3% 0 0 1% 















Differences in study methodology make it difficult to directly compare the results of 
these studies.  However, from the above data, it is evident that the medical 
conditions reported by the participants during various elite international sporting 
events account for a significant volume of the consultations that the team physician 
will need to tend to.  Furthermore, the pattern of conditions reported is remarkably 
consistent through various sporting codes.  It is also evident that specific travel 
related factors such as jet lag and environmental conditions such as seasonal 
patterns can influence the pattern of diseases encountered.  It is thus essential that 
team physicians familiarize themselves with the teams travel plans and the 
competition venue environment when planning medical care. 
 
The limitations of these studies have been identified and due to a growing interest in 
the documentation of medical condition and illness data, two additional studies 
investigating illness data have recently been published.  Of note, the older 
“historical” studies have reported the frequency of illnesses as a percentage of all 
the consultations.  In contrast, the latest research has followed the current standard 
reporting format used to document the incidence of injuries and illness by taking the 
exposure into account (reporting injuries per 1000 player days and illness per 1000 
players).  The types of illness are also reported as a percentage of all the illnesses 
reported.  An important recommendation from this dissertation is that a standard 
illness reporting format be agreed upon and then followed for future studies.  The 
medical condition and illness data from this study can be summarized and 
compared with two recently published studies where the reporting of the data follows 






Table 5.3.:  The frequency (n = number of consultations) and 
percentage (%) of all formal medical consultations and the incidence of 
injuries and illness (expressed as (n) / 1000 athletes or players) in elite 
athletes participating in tournaments (2009 Confederations Cup, 2009 
FINA World Championship and 2010 Winter Olympic Games) 
 Confederations  Cup 
South Africa 
2009 








Injuries (n), % of all consultations (56) 62% (171) 48% (287) 61% 
Injuries / 1000 athletes 304.3 65.6 111.8 
Illnesses (n), % of all consultations (35) 38% (184) 52% (185) 39% 
Illnesses / 1000 athletes 190.2 71.0 72.1 
 Engebretsen119, Mountjoy145 
 
The authors of both the FINA World Championships study and the Winter Olympic 
Games studies have reported the incidence of injuries and illnesses as (n) / 1000 
athletes.  In our study we reported incidence as (n) / 100 player days.  Our opinion is 
that incidence data should be reported using an exposure time.  We would therefore 
suggest that all future research investigating medical conditions and illness be 
reported as (n) / 100 player days. 
 
The third novel contribution from this dissertation is the documentation of the nature 
of medical conditions and illness that elite athletes suffer from during tournaments or 
competitions.  There are data from two recent studies available and these data can 




Table 5.4.:  The frequency of general medical conditions reported in the 
players participating in the 2009 Confederations Cup, 2009 FINA World 
Championships and 2010 Winter Olympic Games (expressed as a % of 
all illnesses)  
 Confederations  Cup 
South Africa 
2009 









Respiratory 57.1% 50.3% 62.8% 
Dermatological 17.1% - 4.4% 
Gastrointestinal 14.3% 19.9% 20% 
Neurological 5.7% - - 
Urological 2.8% - - 
Psychological - - - 
Cardiology - - - 
Ophthalmology 2.8% - - 
Other - 30.4% 12.2% 
Illness causes 
Environmental 42.8% 27.6% 9.8% 
Infection 34.3% 49.2% 63.8% 
Illness symptoms and signs 
Pain 31.4% Most common 27.9% 
Cough 22.8% - 21.2% 
Sore throat 8.6% - - 
Diarrhoea and vomiting 8.6% - 9.5% 
Headache 5.7 - - 
Fever 2.8% - 8.9% 
Diagnosis 
URTI/sinusitis 51.4% - 54.0% 
Otitis - 16.8% - 
Tonsillitis - 9.8% - 
Illness severity 









The most common body system to be affected by illness in our study was the 
respiratory system, followed by the skin and gastrointestinal system.  The most 
common diagnosis was that of sinusitis, followed by influenza.  Fungal skin 
infections were also common.  Pain and coughing were the most prominent 
symptoms reported.  The opinion of the team physicians was that environmental 
factors and infections were the most frequent causes of illness.   
 
A summary of these three studies confirm that respiratory tract symptoms are the 
most common medical problem encountered by team physicians.  This is followed 
by gastrointestinal and dermatological conditions.  The symptom reporting is 
consistent in the three studies, with pain being the most common symptom reported.  
However, the definition of illnesses and accurate diagnostic classification of 
illnesses is not consistent between studies and this needs further research.  In 
particular, the distinction between respiratory and Ear Nose and Throat (ENT) 
conditions needs further clarification.  It is recommended that a consensus be 
reached in the reporting of illness so that, in future, data between studies can be 
compared.   
 
The fourth novel contribution from this dissertation is the documentation of the time 
loss (severity and impact) of medical illness in football players.  From this study the 
time loss due to illness of 0.46 day per illness highlights the importance of medical 
conditions during elite sporting events.  The most common medical condition being 
respiratory tract illness highlights to importance of airway disease and allergic 
conditions for the team physician managing a team. There are no data in the 




players.  However, the general findings of this study are similar to previously 
reported data in other studies. 
 
The results of this dissertation can also be applied to clinical practice and the 
following clinical recommendations can be made based on the data presented in this 
dissertation: 
Sports physicians managing elite football players should be aware of the wide 
spectrum of medical conditions encountered in elite footballers. 
Clinical data from pre-participation screening examinations needs to be 
published to increase the body of knowledge of the prevalence of medical 
condition in athletes. 
 
It is important that the methodology of illness reporting be standardized and that 
future studies report the first consultation and follow-up consultation separately.  
This will enable team physicians to firstly assess the incidence of medical 
conditions and secondly the burden of disease to be managed by the medical 
team taking care of athletes. 
 
There is a growing body of scientific data describing medical conditions and 
illness in athletes. 
 
The high lifetime prevalence of Exercise Associated Muscle Cramping in 





The natural immunity, vaccination status and travel related illnesses, in athletes 
has not been reported. 
 
Assessment of the “local” environment and travel across time zones also need 
to be considered as it has been well documented that aero-allergens, local 
insects, air pollution, weather conditions and jet lag can affect the incidence and 
nature of medical consultations. 
 
Assessment of injury and illness data of elite athletes participating tournaments 
allows for better future planning of the medical coverage of these events. 
 
The composition of the medical team should include members capable of 
managing both injuries and common illnesses. 
 
Finally, the data presented in this dissertation allows us to make some 
recommendations for future studies.  Data collection methodology needs to be 
standardized bearing in mind that there should be sport specific modifications and 
simplification of the questionnaires.  In general, data collection needs to be 
simplified and electronic data collection methods need to be investigated. 
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Table A.1.: 2009 Confederations Cup (South Africa) football tournament 
teams and their respective regional representation or qualifying status   
Team Title 
Brazil Copa America 2007 champions 
Egypt CAF African Cup of Nations 2008 champions 
Iraq AFC Asian Cup 2007 champions 
Italy 2006 FIFA World Cup champions 
New Zealand OFC Nations Cup 2008 champions 
South Africa Host Nation 
Spain UEFA EURO 2008 champions 









SUBJECT INFORMATION SHEET: 
 
THE RESEARCH STUDY TO BE CONDUCTED AT THE  
2009 FIFA CONFEDERAIONS CUP FOOTBALL TOURNAMENT 
 
 
A research study will be conducted to determine how common medical conditions and illnesses are in 
players who are participating in the 2009 FIFA Confederations Cup Football tournament in June 2009. 
This tournament will be held at four venues in South Africa. The detailed information on each of these 
components of the study is as follows:  
 
The purpose of this study is to determine how common a variety of medical conditions and illnesses 
are in football players during a tournament. It is known that athletes, who train hard and then 
participate in strenuous competition, have increased respiratory tract symptoms (runny nose, sore 
throat, sinusitis, enlarged lymph glands in the neck, and even cough and chest pain with fever and 
headaches).  However, these symptoms may not always be due to an infection but could be as a result 
of allergies or pollution. It has also been shown that one of the most common reasons for athletes at 
the Olympic Games see their doctor is gastro-intestinal symptoms and respiratory tract symptoms. 
However, this has not been studied in football players, particularly during competitions. 
You will be given an opportunity to participate in a study where this will be investigated in football 
players. Prior to the competition, your team doctor will approach you and give you information about 
the study. You will then be given the opportunity to volunteer to participate in the study. 
The details of the study are as follows: 
 Before the competition, your team doctor will give you a medical questionnaire to complete. This 
medical questionnaire will be anonymous and only a coding system will be used to identify your 
team. Your personal details will not be on the form. The questionnaire deals with training 
information and medical information.  
 At the time of the competition, your team doctor will ask you every day about possible medical 
conditions. This information will be recorded anonymously on a sheet which will be sent to the 
investigators. If you suffer from any disease/condition, your team doctor will treat it in the usual 
fashion. 
 Further information about any medical conditions that you may have in the 2 weeks after the 
competition will also be recorded by your team doctor and that information will be sent to the 
investigators. 
 
Potential risks of this study  
 The completion of a questionnaire is not associated with any risk.  The questionnaire and other 
clinical data (paper and electronic) will be kept confidential, will be kept secure, and will not be 
made available to any party other than the research team without the consent of the individual 
participants. 
 All medical conditions will be treated by the team doctor.  
 
Potential benefits of this study 
 The anticipated benefits of this study are that the results will further our understanding of the 
possible cause/s of medical conditions in football players that travel to participate in international 
competitions.  
 
As a participant in the 2009 Confederations Cup, you are given the choice to participate in this 
research effort. Your participation is entirely voluntary. Please read through the details of the study. 




please read through and sign the INFORMED CONSENT FORM. Please feel free to contact your team 
doctor or members of the research team should you have any questions related to the study. Contact 







INFORMED CONSENT FORM 
I, _________________________________, agree voluntarily to participate in a study conducted by the 
UCT/MRC Research Unit for Exercise Science and Sports Medicine (University of Cape Town) and the 
FIFA Medical Assessment and Research Centre (FMARC), titled: 
“Medical conditions and illness in elite football players during international competition: a pilot 
study” 
I understand that my participation in this research project has no direct benefits to me during the 2009 
FIFA Confederations Cup competition.  However, I understand that my participation in the research 
project will advance the medical and scientific knowledge related to football. Therefore, information 
gathered through my participation in this project could advance the future medical care, training advice 
and performance of football players. 
I have read the subject information sheet and the following procedures and concepts have been 
explained to me in full: 
Completion of a questionnaire:  (all components) 
The questionnaire will not contain any personal particulars (name, contact details) that could identify 
me. The completion of training details, medical conditions, and lifestyle history questionnaires are not 
associated with any risk.  All the questionnaire data and other clinical data (paper and electronic) will 
be kept confidential, will be kept secure, and will not be made available to any party other than the 
research team without the consent of the individual subjects. 
I agree that the all the information, which will be collected by my team doctor before the tournament, 
may be used to answer scientific questions about the medical conditions associated with the 
participation in and completion of an football tournament. 
Daily information during the football tournament and in the 2 weeks after tournament 
I agree that the all the information, which will be collected by my team doctor on a daily basis during 
and for 2 weeks after the tournament, may be used to answer scientific questions about the medical 
conditions associated with the participation in and completion of an football tournament.   
I have read (or, where appropriate, have had read to me) and understood the information about 
this study, and any questions I have asked have been answered to my satisfaction.  I agree to 
participate in the study.  I agree that research data provided by me or with my permission 
during the study may be included in a thesis, presented at conferences and published in 
journals on the condition that neither my name nor any other identifying information is used. 
I have read the preceding subject information sheet and understand the testing procedures outlined 
therein. I understand any accompanying risks and discomforts. Knowing these risks and discomforts 
and having had the opportunity to pose questions answered to my satisfaction, I hereby consent to 
participate in this study. I understand that I may withdraw from this study at any time without further 
question.  I have been informed that the individual data derived from my participation in these protocols 
will remain confidential. I understand that the medical staff and the research team have professional 
medical insurance. 
 
Name of the player:  
    
Name of investigator:   
  
 
Signature of the player 
 














2009 CONFEDERATIONS CUP  
PRE-COMPETITION MEDICAL QUESTIONNAIRE 
 
These questionnaires have been constructed by the Medical Research team, 
in conjunction with FIFA Medical Assessment and Research Centre (FMARC).  
The information obtained from these questionnaires is essential for the 
planning of medical care during events such as the FIFA Confederations Cup. 
We acknowledge that the questionnaire is long, but we are asking about 20-30 
minutes of your valuable time to complete them. The completion of the 
questionnaires is voluntary; all the information will be kept confidential and 
will only be used for research and medical care planning purposes.  
 
Prof Martin Schwellnus  
Prof Jiri Dvorak 
 
Instructions 
Please answer each question by filling in the details in the allocated space or 
checking one or more of the option boxes. 
Please hand the completed forms together with the signed consent form to your 
team physician. 
Section A Basic Details 
Section B Training History 
Section C 
History of Medication and Supplement Use as well as Lifestyle 
and Habits History 








Section E General Personal Medical History 
 
Section A: Basic player details 
Team Code 
      
Players Code 
      
First Name 
      
Date of birth 
y y y y - m m - d d       
Height       cm 
Weight       kg 
Age (on first day of 
competition) 
       yrs 
Dominant Hand 
Left     Right    Both  Dominant Leg Left    Right   Both  
Player position       
  
Section B. Training history 
How many days a week did you train during 15 weeks before the competition? 
 days/wk 
How many hours a week did you train in an average week during the 15 weeks before 
the competition? 
 hrs/wk 
Please indicate what types of training you 
perform and the percentage of training during 
15 weeks before the competition?  
 Football training on the pitch                           ___ % 
 Strength training in a gymnasium                     ___ %  
 Endurance training (running, jogging, cycling) ___ % 
 Flexibility / agility training                                 ___ % 
 Other training ________________                   ___ % 
How many days a week did you train during 2 weeks before the competition? 
 days/wk 
How many hours a week did you train in an average week during the 2 weeks before the 
competition? 
 hrs/wk  
Please indicate what types of training you 
perform and the percentage of training during 2 
weeks before the competition?  
 Football training on the pitch                           ___ % 
 Strength training in a gymnasium                     ___ %  
 Endurance training (running, jogging, cycling) ___ % 
 Flexibility / agility training                                 ___ % 




How did your training commitment affect your social life? 
 Not at all  
 A fair amount  
 A lot  
Section C. History of medication and supplement use 
What medication, if any, are you currently 
using? (please list) 
Name of medication 
Years taken 
            
            
            
            
Are you currently taking dietary supplements/vitamins? 
Yes  No  
If yes to the above question, please list 
names of dietary, sports or vitamin 
supplements. 
Name of supplement 
Years taken 
 Multi-vitamins    _____ 
 Anti-oxidants     _____ 
 Immune boosters     _____ 
 Protein powders/supplements, Protein bars. BCAAs  _____ 
 Creatine       _____ 
 Caffeine      _____ 
 Fat cutters      _____ 
 Carbohydrate drinks/powders/gels   _____ 
 Other: _____________________________  _____ 
Lifestyle and habits history 
Please indicate your smoking status Current smoker   Ex smoker   Never smoked   
If you answered yes, (past 
or current smoker) please 
complete the section on the 
right 
Number of years of smoking:       If stopped, how many years ago:       
What is (was) the average number of cigarettes per day:       
On average, how much alcohol do you drink per week (tots, glasses) of 
spirits, wine or beer? 
_______  glasses beer/cider per week 
_______  glasses wine per week 








Section D. Family medical history 
Have any of your blood (biological) relatives ever had the following?  
Please tick yes or no. If yes, please tick the relationship of that person to you (You may tick more than one of the 
relationship blocks).  
Description 
 If Yes, please indicate the relationship  
Asthma Yes  No  
 Father      Mother         Brother   
  Sister    Child 
 Grandfather      Grandmother  
Allergies (in general) Yes  No  
 Father      Mother         Brother   
  Sister    Child 






















Section E. General personal medical history 
In this section, you are asked to read through 8 questions about your personal general medical history. If you 
answer “yes” to any of questions, please complete the additional questions about that symptom/condition.  
Question 1: Flu symptoms 
In the 6 weeks before the competition (from 1
st
 May) did you suffer from any symptoms of 
flu (fever, sore throat, blocked or runny nose, cough, wheeze, muscle aches and pains)? 
Yes  No  
If you answered NO to question 1 – Please go to Question 2 below 
If you answered YES to question 1 - please complete the following additional questions 
(1a) Please tick which of these flu 
symptoms you suffered from in the 
last 6 weeks. 
 Fever   Cough  Joint pains 
 Blocked nose   Wheezing  Sore Throat 
 Runny nose   Muscle aches 
 Any other flu symptoms   
      (Specify: _____________________________) 
(1b) Please tick which of these flu 
symptoms you suffered from in the 
last 7 days. 
 Fever   Cough  Joint pains 
 Blocked nose   Wheezing  Sore Throat 
 Runny nose   Muscle aches 
 Any other flu symptoms   
      (Specify: _____________________________) 
 
Question 2: Allergy symptoms 
Have you ever in your football career suffered from symptoms of allergies including nose 
allergies (hay fever), allergic sinusitis, allergic asthma, skin allergies, a past history of allergies to 
medication, plant material or animal material? 
Yes  No  
If you answered NO to question 2 – Please go to Question 3 below 
If you answered YES to question 2 - please complete the following Table 
(7a) Please indicate how long (years) have you been suffering from allergies? 
        years 
(7b) Please tick which type of allergy do you currently suffer from 
Nose (hay fever) 
Yes  No  Sinusitis Yes  No  
Asthma 
(allergic) 





Yes  No  Eye allergies Yes  No  
Allergy to plant 
material 
Yes  No  
Allergy to foods 
Yes  No  Allergy to animals Yes  No  
Allergy to 
medication 
Yes  No  
(7c) Please tick which type of allergy do you currently take medication for 
Nose (hay fever) 
Yes  No  Sinusitis Yes  No  
Asthma 
(allergic) 
Yes  No  
Skin allergies 
Yes  No  Eye allergies Yes  No  
Allergy to plant 
material 
Yes  No  
Allergy to foods 
Yes  No  Allergy to animals Yes  No  
Allergy to 
medication 
Yes  No  
(7d) Please tick which type of medication do you currently take 
Cortisone nose 
spray 
Yes  No  
Cortisone nose 
inhaler 
Yes  No  
Anti-histamine 
tablets 
Yes  No  
Cortisone cream 
Yes  No  
Anti-histamine 
cream 
Yes  No  
Other inhaler / 
tablets or 
cream 
Yes  No  
(7e) Please tick which symptoms of allergy do you currently suffer from  
Sneezing 
Yes  No  Itchy runny nose Yes  No  Headache Yes  No  
Itchy palate 
Yes  No  Streaming eyes Yes  No  Fatigue Yes  No  
Itchy eyes 
Yes  No  Blocked nose Yes  No  Poor sleep Yes  No  
Post nasal drip 
Yes  No  Coughing Yes  No  Wheezing Yes  No  
In which months of the year do you 
currently have symptoms of allergies? 
(You tick more than one) 
 Jan   Feb     March    April  May     June    
 July    Aug    Sept      Oct  Nov     Dec 
(7f) Please tick which type of allergy did you suffer from in the past (NOT currently) 
Nose (hay fever) 
Yes  No  Sinusitis Yes  No  
Asthma 
(allergic) 
Yes  No  
Skin allergies 
Yes  No  Eye allergies Yes  No  
Allergy to plant 
material 
Yes  No  
Allergy to foods 
Yes  No  Allergy to animals Yes  No  
Allergy to 
medication 










Question 3: Asthma 
Do you currently suffer from asthma including exercise induced asthma, or symptoms of 
asthma such as shortness of breath, wheezing, or chronic coughing? 
Yes  No  
If you answered NO to question 3 – Please go to Question 4 below 
If you answered YES to question 3 - please complete the following questions 
(8a) How many years have you suffered from asthma? 
       (years) 
(8b) How was your asthma 
diagnosed?  
 A doctor taking a history and performing an examination 
 Lung function test (blow test) but no exercise 
 Lung function test (blow test) before and after exercise 
 Metacholine challenge test 
 Eucapnic hyperventilation test (rebreathing test) 
 Other test  (Specify:  ________________________) 
(8c) Which type of asthma do 
you currently suffer from? 
 Asthma that occurs at any time but not during exercise 
 Asthma that occurs at any time including during exercise 
 Asthma that only occurs during exercise 
(8d) Please indicate how 
frequently do you currently 
experience the symptoms of 
asthma (shortness of breath, 
wheezing, coughing or 
coughing after exercise)? 
Daytime symptoms (per week) 
 < 2 / week       2-4 / week        >4 / week          All the time 
Night time symptoms (per month) 
 < 1 / month       2-3 / month        >4 / month        All the time 
Exercise related symptoms (per 10 exercise sessions) 
 <1 per 10 sessions    2-3 per 10 sessions    >4 per 10 sessions 
(8e) Please indicate if you had 
symptoms of asthma that were 
severe enough to necessitate 
hospital admission in the last 
12 months 
 No hospital admission for asthma in the last 12 months  
 1-2 hospital admissions for asthma in the last 12 months  
 3-4 hospital admissions for asthma in the last 12 months  




(8f) Which symptoms of 
asthma do you currently suffer 
from? 
 Wheezing   Dry cough   Shortness of breath 
 Tight chest   Chest pain  
 Other (Specify: ________________________) 
(8g) What medication do you 
currently use for your asthma? 
(you may tick more than one 
option) 
 Cortisone inhaler (e.g. Beclate, Becloforte, Becodisks, Becotide, Budeflam, 
Flixotide, Inflammide, Pulmicort, Qvar, etc)   
 Salbutamol (bronchodilator) inhaler (e.g. Ventolin, Venteze, Vomax, Airomir, 
Asthavent etc.) 
 Salmeterol (bronchodilator) inhaler (Serevent) 
 Fenoterol (bronchodilator) inhaler (Berotec) 
 Terbutaline (bronchodilator) inhaler (Bricanyl) 
 Formoterol (bronchodilator) inhaler (e.g. Foradil, Foratec, Oxis) 
 Ipratropium (bronchodilator) inhaler (Atrovent) 
 Tiotropium (bronchodilator) inhaler (Spiriva) 
 Combined cortisone and bronchodilator  inhaler (e.g. Atrovent, Berodual, 
Combivent, Duolin, Duovent, Seretide, Symbicord)  
 Cortisone tablets 
 Bronchodilator tablets 
 Leukotriene receptor antagonist tablets (e.g. Acccolate, Singulair) 
 Other inhaler  
 Other medication (Specify: ________________________) 
(8h) When do you use your 
medication for your asthma? 
 Daily (irrespective of exercise)  Only before exercise 
 Other (Specify: ________________________) 
(8i) How long before an exercise session do you use your medication for asthma? 
      min 












Question 4: Muscle cramping during football 
Have you ever in your football career suffered from muscle cramping (painful, 
spontaneous, sustained spasm of a muscle) during or immediately (within 6 hours) 
after exercise (in training or competition)?  
Yes  No  
If you answered NO to question 4 – Please go to Question 5 below 
If you answered YES to question 4 - please complete the following additional questions 
(2a) For how many years have you suffered from cramping? 
       (years) 
(2b) Did you suffer from cramping during or after exercise in the last 12 
months? 
Yes  No  
(2c) With what type of training is your cramping 
associated (You can tick more than one form of 
exercise)? 
 Football    Weight training 
 Running   Other 
(2d) In the last 10 matches or training sessions, how 
many times have you experienced cramping? 
Matches:  _____/10 
Training sessions:  _____/10 
(2e) What treatment/s have you had 
that successfully relieved an acute 
cramp? (can tick more than one) 
 Stretching        Resting  
 Drinking fluid  Ice application 
 Massage       Magnesium 
 Salt (tablets or solution) 
 Other  (Specify: _____________________________) 
(2f) At what point in the 
competition or training session do 
you usually first experience 
cramping? 
 First quarter   Second quarter  
 Third quarter                Fourth quarter 
 After the session   No pattern 
(2g) In which muscles do you 
usually cramp (please list the muscle 
by the one which cramps most 
frequently (as 1) and the others after 
that (2-4)? 
 Calves   Hamstrings  
 Quadriceps (thigh)  Foot muscles 
 Other  (Specify: _____________________________) 
(2h) Have you ever suffered from cramping in your whole body (arms and legs)? Yes  No  
(2i) Have you ever been admitted to hospital following cramping? Yes  No  
(2j) Have you ever been confused or in a coma during or after a cramping 
episode? 




(2k) Have you ever had “dark urine” in the 3 days following a cramping episode? Yes  No  
(2l) If you cramp, how long does the cramp usually last for (min)?      (minutes) 
(2m) If you cramp, how severe is the cramp usually? 
(please tick). 
 Mild: < 5 minutes and you are able to continue exercising 
 Moderate: 5-15 minutes and you are able to continue 
exercising 
 Severe: >15 minutes or if  you have to STOP exercising 
 
 
Question 5: Gastro-intestinal symptoms during football 
Have you ever in your running career suffered gastrointestinal symptoms during football 
including heartburn, nausea, vomiting, abdominal pain, urge to defecate (pass a stool), diarrhoea, 
or blood in the stools? 
Yes  No  
If you answered NO to question 5 – Please go to Question 6 below 






symptom in the 





Number of times 
you experienced 
the GIT symptom 




Please indicate the “severity” of the GIT symptom 
during training or playing football 
Nausea        
 Does not affect training or playing 
 Affects training/playing football (slow down or reduce 
time) 
 Prevents training/playing football 
Vomiting             
 Does not affect training or playing 
 Affects training/playing football (slow down or reduce 
time) 
 Prevents training/playing football 
Heartburn             
 Does not affect training or playing 
 Affects training/playing football (slow down or reduce 
time) 




Abdominal pain             
 Does not affect training or playing 
 Affects training/playing football (slow down or reduce 
time) 
 Prevents training/playing football 
Urge to pass a stool 
(defecate) 
            
 Does not affect training or playing 
 Affects training/playing football (slow down or reduce 
time) 
 Prevents training/playing football 
Diarrhoea             
 Does not affect training or playing 
 Affects training/playing football (slow down or reduce 
time) 
 Prevents training/playing football 
Passing blood in the 
stool 
                 
 Does not affect training or playing 
 Affects training/playing football (slow down or reduce 
time) 
 Prevents training/playing football 
Please indicate if you previously suffered from or had any 
of the following (you may tick more than one)? 
 History of heartburn  
 Gastroscopy 
 Ulcer (gastric, duodenal) 
 Irritable bowel syndrome 
 Allergy to milk products 











Question 6: Nervous system symptoms during football 
Have you ever in your football career suffered from symptoms of the nervous system including 
exercise induced headaches, depression, anxiety, nerve tingling or loss of sensation? 
Yes  No  
If you answered NO to question 6 – Please go to Question 7 below 
If you answered YES to question 6 - please complete the following Table 
Symptom 
Number of times 










Please indicate the “severity” of the symptom during 
training or playing football 
Headaches             
 Does not affect training or playing 
 Affects training/playing football (slow down or reduce 
time) 
 Prevents training/playing football 
Depression   
 Does not affect training or playing 
 Affects training/playing football (slow down or reduce 
time) 
 Prevents training/playing football 
Anxiety   
 Does not affect training or playing 
 Affects training/playing football (slow down or reduce 
time) 
 Prevents training/playing football 
Nerve tingling in 
the hands 
            
 Does not affect training or playing 
 Affects training/playing football (slow down or reduce 
time) 
 Prevents training/playing football 
Loss of sensation 
in the hands 
            
 Does not affect training or playing 
 Affects training/playing football (slow down or reduce 
time) 




Nerve tingling in 
the feet 
            
 Does not affect training or playing 
 Affects training/playing football (slow down or reduce 
time) 
 Prevents training/playing football 
Loss of sensation 
in the feet 
            
 Does not affect training or playing 
 Affects training/playing football (slow down or reduce 
time) 
 Prevents training/playing football 
 
Question 7 and 8: Other medical history 
7. Do you currently, or did you in the last 
year, suffer from any symptoms of skin 
disease? 
Skin infections:  Yes    No  
Skin allergy:  Yes    No  
Sunburn:   Yes    No  
Skin cancer:   Yes    No  




8. Please tick in which anatomical area 
you ever had surgery performed. 
 Gastric (stomach)  Oesophageal (swallowing pipe) 
 Small bowel      Large bowel (colon) 
 Rectum                Gallbladder 
 Pancreas                Liver 
 Abdomen (general    )   Wrist 
 Head    Finger 
 Neck   Lower back 
 Face   Hip  
 Front chest   Thigh 
 Back chest    Knee 
 Shoulder   Lower leg 
 Upper arm   Achilles 
 Elbow   Ankle 
 Forearm   Foot 























TABLE A.2.: FIFA 2009 Confederation Cup tournament fixtures and 
respective player days  
DAY DATE MATCH 
(TIME) 
TEAMS VENUE MATCH 
(TIME) 






























































































































































Table A.3.: Weather data reported by the South African Weather Service 
for the duration of the 2009 Confederations Cup at each of the 
tournament host cities 
Johannesburg Mangaung Rustenburg Tshwane 
Altitude 1695m 1353m 1695m 1308m 
Highest 
temperature 
20.7°C 20.9°C 25.5°C 23.7°C 
Average maximum 16.5 ± 2.5°C 16.4 ± 4.1°C 21.3 ±2.4°C 19.9 ± 2.2°C 
Lowest 
temperature 
-0.7°C -4.9°C -1.2°C 0.4°C 
Average minimum 6.2 ± 3.4°C 1.0 ± 4.4°C 7.3 ± 3.6°C 7.4 ± 3.5°C 
Total rainfall 2.4mm 7.2mm 0.8mm 0.6mm 
Average wind 
speed 08h00 
4.2 ± 2.3m/s 1.1 ± 1.8m/s 1.0 ± 1.3m/s 0.4 ± 0.7m/s 
Average wind 
speed 14h00 
5.3 ± 2.3m/s 4.5 ± 2.0m/s 2.3 ± 1.0m/s 1.9 ± 0.6m/s 
Average wind 
speed 20h00 
2.9 .6m/s 1.8 ± 1.7m/s 1.3 ± 0.7m/s 0.1 ± 0.4m/s 
Average humidity 
08h00 
71.5 ± 13.8% 90.9 ± 5.2% 73.1 ± 14.1% 73.8 ± 9.9% 
Average humidity 
14h00 
33.9 ± 12.2% 45.1 ± 9.4% 32.2 ± 11.9% 32.8 ± 11.3% 
Average humidity 
20h00 
50.3 ± 14.7% 74.1 ± 8.0% 58.9 ± 15.1% 55.9 ± 15.0% 
